96 results
Search Results
2. The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro.
- Author
-
Bien-Möller, Sandra, Chen, Fan, Xiao, Yong, Köppe, Hanjo, Jedlitschky, Gabriele, Meyer, Ulrike, Tolksdorf, Céline, Grube, Markus, Marx, Sascha, Tzvetkov, Mladen V., Schroeder, Henry W. S., and Rauch, Bernhard H.
- Subjects
ANIMAL experimentation ,CULTURE media (Biology) ,GLIOMAS ,CELL receptors ,ANTINEOPLASTIC agents ,CULTURES (Biology) ,CELL motility ,CELL survival ,IMMUNOBLOTTING ,CELLULAR signal transduction ,TRANSFERASES ,RESEARCH funding ,CELL lines ,DRUG resistance in cancer cells ,ANTIGENS ,MONOCYTES ,PHARMACODYNAMICS - Abstract
Simple Summary: In this paper, we report on the inhibition of glioblastoma (GBM) cell growth and migration by the putative S1PR1 modulator ACT-2009905, using appropriate in vitro models. This work is based on our previously published finding that S1PR1 expression is strongly up-regulated in human glioblastoma samples and the fact that there is an association between S1PR1 with patients' survival times. We now show that pharmacological modulation by the putative S1PR1 modulator ACT-209905 inhibits GBM cell growth and migration. Furthermore, we investigated the influence of co-culture of GBM cells with THP-1 cells as a model for human monocytes, showing pro-tumoral effects and arguing for a complex interplay between GBM cells, immune cells and underlying signaling pathways. We believe that this manuscript fits the interests of the readership of the journal Cancers as it addresses the impact of alternative therapeutic options using ACT-209905 for improving GBM therapy. Glioblastoma (GBM) is still a deadly tumor due to its highly infiltrative growth behavior and its resistance to therapy. Evidence is accumulating that sphingosine-1-phosphate (S1P) acts as an important tumor-promoting molecule that is involved in the activation of the S1P receptor subtype 1 (S1PR1). Therefore, we investigated the effect of ACT-209905 (a putative S1PR1 modulator) on the growth of human (primary cells, LN-18) and murine (GL261) GBM cells. The viability and migration of GBM cells were both reduced by ACT-209905. Furthermore, co-culture with monocytic THP-1 cells or conditioned medium enhanced the viability and migration of GBM cells, suggesting that THP-1 cells secrete factors which stimulate GBM cell growth. ACT-209905 inhibited the THP-1-induced enhancement of GBM cell growth and migration. Immunoblot analyses showed that ACT-209905 reduced the activation of growth-promoting kinases (p38, AKT1 and ERK1/2), whereas THP-1 cells and conditioned medium caused an activation of these kinases. In addition, ACT-209905 diminished the surface expression of pro-migratory molecules and reduced CD62P-positive GBM cells. In contrast, THP-1 cells increased the ICAM-1 and P-Selectin content of GBM cells which was reversed by ACT-209905. In conclusion, our study suggests the role of S1PR1 signaling in the growth of GBM cells and gives a partial explanation for the pro-tumorigenic effects that macrophages might have on GBM cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma.
- Author
-
Khazaei Monfared, Yousef, Mahmoudian, Mohammad, Zakeri-Milani, Parvin, Cecone, Claudio, Hayashi, Tomoya, Ishii, Ken J., Conde, João, Matencio, Adrián, and Trotta, Francesco
- Subjects
FLOW cytometry ,GLUCANS ,MELANOMA ,ANIMAL experimentation ,CELL membranes ,LEUCOCYTES ,ANTINEOPLASTIC agents ,TREATMENT effectiveness ,MESSENGER RNA ,POLYMERS ,RESEARCH funding ,CELL surface antigens ,IMMUNOTHERAPY ,MICE ,IMMUNODIAGNOSIS ,ANTIGENS - Abstract
Simple Summary: The frequency of metastatic melanoma, an extremely deadly malignancy, is rapidly increasing worldwide. Recently, messenger RNA (mRNA) injections have emerged as a promising treatment option. While mRNA therapies have demonstrated significant promise, the stability of the naked form remains a barrier, as naked mRNAs are vulnerable to common ribonucleases, and are unable to effectively penetrate plasma membranes and escape from endosomes. Thus, for this paper, we used a hyper-branched cyclodextrin-based polymer (Ppoly) as a carrier to enhance mRNA delivery for melanoma cancer. The in vitro results demonstrated that Ppoly was able to deliver the EGFP-mRNA effectively in both 2D and 3D melanoma cell lines compared to naked mRNA; in addition, Ppoly did not show any cytotoxicity. The anti-tumour effect of intratumourally injected OVA-mRNA loaded on Ppoly results showed a significant decrease in both tumour size and weight compared to other formulations by inducing an efficient adaptive immune response and OVA-specific CD8+ T cells in both spleen and tumour tissues compared to other groups. mRNA technology has demonstrated potential for use as an effective cancer immunotherapy. However, inefficient in vivo mRNA delivery and the requirements for immune co-stimulation present major hurdles to achieving anti-tumour therapeutic efficacy. Therefore, we used a cationic hyper-branched cyclodextrin-based polymer to increase mRNA delivery in both in vitro and in vivo melanoma cancer. We found that the transfection efficacy of the mRNA-EGFP-loaded Ppoly system was significantly higher than that of lipofectamine and free mRNA in both 2D and 3D melanoma cancer cells; also, this delivery system did not show cytotoxicity. In addition, the biodistribution results revealed time-dependent and significantly higher mEGFP expression in complexes with Ppoly compared to free mRNA. We then checked the anti-tumour effect of intratumourally injected free mRNA–OVA, a foreign antigen, and loaded Ppoly; the results showed a considerable decrease in both tumour size and weight in the group treated with OVA-mRNA in loaded Ppoly compared to other formulations with an efficient adaptive immune response by dramatically increasing most leukocyte subtypes and OVA-specific CD8+ T cells in both the spleen and tumour tissues. Collectively, our findings suggest that the local delivery of cationic cyclodextrin-based polymer complexes containing foreign mRNA antigens might be a good and reliable concept for cancer immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters
- Author
-
Zhao, Binan, Peng, Haoran, Zhang, Yanjing, Zhang, Jie, Kong, Desheng, Cao, Sai, Li, Yan, Yang, Dan, Sun, Chuanwen, Pu, Xinyi, Zhao, Ping, Xu, Yan, Zhao, Kai, and Xie, Liangzhi
- Published
- 2024
- Full Text
- View/download PDF
5. Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer Growth via miR-299-3p/TGIF1 Axis.
- Author
-
Li, Rong, Xu, Xuejing, Gao, Shuo, Wang, Junyi, Hou, Jie, Xie, Zhenfan, Luo, Lan, Shen, Han, Xu, Wenrong, and Jiang, Jiajia
- Subjects
STOMACH tumors ,CIRCULAR RNA ,FLOW cytometry ,IN vitro studies ,XENOGRAFTS ,IN vivo studies ,RNA-binding proteins ,WESTERN immunoblotting ,ANIMAL experimentation ,MICRORNA ,SMALL interfering RNA ,PRECIPITIN tests ,APOPTOSIS ,SIGNAL peptides ,BIOINFORMATICS ,CELL survival ,GENES ,CELL proliferation ,RESEARCH funding ,GENETIC techniques ,COLORIMETRY ,BIOLOGICAL assay ,POLYMERASE chain reaction ,ANTIGENS ,CASPASES ,MICE ,EVALUATION - Abstract
Simple Summary: Gastric cancer (GC) is one of the most common malignancies with limited therapeutic targets available. CDR1as, an endogenous circular RNA with a closed loop structure, has been reported to be a crucial regulator and promising biomarker in various tumors. However, whether and how CDR1as participates in GC progression remains not well characterized. In this study, we explored the biological roles, the downstream molecular mechanism and the upstream regulator of CDR1as in GC. We found that CDR1as mediated by human antigen R (HuR) promotes GC growth through the miR-299-3p/TGIF1 axis, which provides new insights into GC pathogenesis and brings a new potential target for clinical GC therapy. Background: Gastric cancer (GC) remains a common malignancy worldwide with a limited understanding of the disease mechanisms. A novel circular RNA CDR1as has been recently reported to be a crucial regulator of human cancer. However, its biological role and mechanism in the GC growth are still far from clear. Methods: Small interfering RNAs (siRNAs), lentivirus or plasmid vectors were applied for gene manipulation. The CDR1as effects on the GC growth were evaluated in CCK8 and colony formation assays, a flow cytometry analysis and mouse xenograft tumor models. A bioinformatics analysis combined with RNA immunoprecipitation (RIP), RNA pull-down assays, dual-luciferase reporter gene assays, Western blot, reverse transcription–quantitative polymerase chain reaction (RT-qPCR) and functional rescue experiments were used to identify the CDR1as target miRNA, the downstream target gene and its interaction with human antigen R (HuR). Results: The CDR1as overexpression promoted the GC growth in vitro and in vivo and reduced the apoptotic rate of GC cells. Its knockdown inhibited the GC cell proliferation and viability and increased the cell apoptotic rate. Proliferation-related proteins PCNA and Cyclin D1 and apoptosis-related proteins Bax, Bcl-2, Caspase-3 and Caspase-9 were regulated. Mechanically, the cytoplasmic CDR1as acted as a miR-299-3p sponge to relieve its suppressive effects on the GC cell growth. Oncogenic TGIF1 was a miR-299-3p downstream target gene that mediated the promotive effects of CDR1as and regulated the PCNA and Bax levels. HuR interacted with CDR1as via the RRM2 domain and positively regulated the CDR1as level and its oncogenic role as well as downstream target TGIF1. Conclusions: CDR1as promotes the GC growth through the HuR/CDR1as/miR-299-3p/TGIF1 axis and could be used as a new therapeutic target for GC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma.
- Author
-
Candelaria, Pierre V., Nava, Miguel, Daniels-Wells, Tracy R., and Penichet, Manuel L.
- Subjects
IN vitro studies ,IMMUNOGLOBULINS ,IN vivo studies ,ANIMAL experimentation ,ANTINEOPLASTIC agents ,MACROPHAGES ,GENE expression ,MOLECULAR biology ,RESEARCH funding ,MULTIPLE myeloma ,DRUG development ,CELL lines ,ANTIGENS ,MONOCYTES ,MICE ,PHARMACODYNAMICS - Abstract
Simple Summary: Multiple myeloma (MM) is blood cancer of plasma cells. Plasma cells are white blood cells, which are part of the immune system. Malignant plasma cells are found in the bone marrow and are difficult to treat. There have been many new therapies developed in recent years, but the disease is still considered incurable. Some of the treatments for MM are antibodies of the IgG class. We have developed a fully human antibody of another antibody class, IgE, targeting the CD38 molecule that is expressed on the surface of several cancers including MM. Our goal is to use the anti-CD38 IgE antibody to recruit different types of immune cells to kill malignant cells. In this article, we report that the antibody shows anti-cancer effects against MM cells. Thus, this IgE antibody should be further explored as a novel treatment for MM. Multiple myeloma (MM) is an incurable malignancy of plasma cells and the second most common hematologic malignancy in the United States. Although antibodies in clinical cancer therapy are generally of the IgG class, antibodies of the IgE class have attractive properties as cancer therapeutics, such as their high affinity for Fc receptors (FcεRs), the low serum levels of endogenous IgE allowing for less competition for FcR occupancy, and the lack of inhibitory FcRs. Importantly, the FcεRs are expressed on immune cells that elicit antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cell-mediated phagocytosis (ADCP), and/or antigen presentation such as mast cells, eosinophils, macrophages, and dendritic cells. We now report the development of a fully human IgE targeting human CD38 as a potential MM therapy. We targeted CD38 given its high and uniform expression on MM cells. The novel anti-CD38 IgE, expressed in mammalian cells, is properly assembled and secreted, exhibits the correct molecular weight, binds antigen and the high affinity FcεRI, and induces degranulation of FcεRI expressing cells in vitro and also in vivo in transgenic BALB/c mice expressing human FcεRIα. Moreover, the anti-CD38 IgE induces ADCC and ADCP mediated by monocytes/macrophages against human MM cells (MM.1S). Importantly, the anti-CD38 IgE also prolongs survival in a preclinical disseminated xenograft mouse model using SCID-Beige mice and human MM.1S cells when administered with human peripheral blood mononuclear cells (PBMCs) as a source of monocyte effector cells. Our results suggest that anti-CD38 IgE may be effective in humans bearing MM and other malignancies expressing CD38. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer.
- Author
-
Li, Dong, Hemati, Hami, Park, Younhee, Taftaf, Rokana, Zhang, Youbin, Liu, Jinpeng, Cristofanilli, Massimo, and Liu, Xia
- Subjects
IN vivo studies ,IMMUNE checkpoint inhibitors ,ANIMAL experimentation ,WESTERN immunoblotting ,IMMUNOHISTOCHEMISTRY ,METASTASIS ,NEUTROPHILS ,BIOINFORMATICS ,RESEARCH funding ,TUMOR markers ,CELL lines ,POLYMERASE chain reaction ,BREAST tumors ,ANTIGENS ,HYDROGEN peroxide ,ANIMALS ,MICE - Abstract
Simple Summary: The binding of neutrophils with circulating tumor cells (CTCs) enhances the metastatic ability of CTCs. However, the mechanism by which neutrophils bind to CTCs remains elusive. In this study, we found that intercellular adhesion molecule-1 (ICAM-1) on triple-negative breast cancer (TNBC) cells and CD11b on neutrophils mediate tumor cell–neutrophil binding. Consequently, CD11b deficiency inhibits tumor cell–neutrophil binding and metastasis. Moreover, we found that ICAM-1 in TNBC cells promotes tumor cells to secrete soluble urokinase-type plasminogen activator receptor (suPAR), which functions as a chemoattractant for neutrophils. Knockdown of uPAR in TNBC cells reduced lung-infiltrating neutrophils and lung metastasis. Our findings suggest that blocking the ICAM-1-suPAR-CD11b axis might be a novel therapeutic strategy to inhibit TNBC metastasis. Accumulating evidence demonstrates that circulating tumor cell (CTC) clusters have higher metastatic ability than single CTCs and negatively correlate with cancer patient outcomes. Along with homotypic CTC clusters, heterotypic CTC clusters (such as neutrophil–CTC clusters), which have been identified in both cancer mouse models and cancer patients, lead to more efficient metastasis formation and worse patient outcomes. However, the mechanism by which neutrophils bind to CTCs remains elusive. In this study, we found that intercellular adhesion molecule-1 (ICAM-1) on triple-negative breast cancer (TNBC) cells and CD11b on neutrophils mediate tumor cell–neutrophil binding. Consequently, CD11b deficiency inhibited tumor cell–neutrophil binding and TNBC metastasis. Furthermore, CD11b mediated hydrogen peroxide (H
2 O2 ) production from neutrophils. Moreover, we found that ICAM-1 in TNBC cells promotes tumor cells to secrete suPAR, which functions as a chemoattractant for neutrophils. Knockdown of uPAR in ICAM-1+ TNBC cells reduced lung-infiltrating neutrophils and lung metastasis. Bioinformatics analysis confirmed that uPAR is highly expressed in TNBCs, which positively correlates with higher neutrophil infiltration and negatively correlates with breast cancer patient survival. Collectively, our findings provide new insight into how neutrophils bind to CTC to facilitate metastasis and discover a novel potential therapeutic strategy by blocking the ICAM-1-suPAR-CD11b axis to inhibit TNBC metastasis. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
8. THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation.
- Author
-
Chen, Luo, Chau, Wai Yin, Yuen, Hei Tung, Liu, Xiao Han, Qi, Robert Zhong, Lung, Maria Li, and Lung, Hong Lok
- Subjects
NASOPHARYNX cancer ,CELL membranes ,ANIMAL experimentation ,PROTEIN kinase inhibitors ,SMALL interfering RNA ,CELL receptors ,PRECIPITIN tests ,TREATMENT failure ,MEMBRANE glycoproteins ,PROTEOMICS ,TRANSFERASES ,GENES ,RESEARCH funding ,CELL lines ,ANTIGENS ,NASOPHARYNX tumors ,MICE ,PHENOTYPES - Abstract
Simple Summary: Nasopharyngeal carcinoma (NPC) is endemic to southern China and cancer metastasis remains the main cause of treatment failures. Previously we have found THY1, a cell surface glycoprotein, inhibits the invasion of NPC cells and functions as a tumor suppressor in NPC. In the present study, we further illustrated the mechanism that contributes to the tumor suppressive function of THY1. Two binding partners of THY1, PDGF-Rβ and PTPN22, were identified, and PTPN22 represents the downstream signaling molecule of THY1 to inhibit the PDGF-Rβ–induced SRC activity. The anti-metastatic effect of SRC inhibition was subsequently validated in a mice model with administration of a SRC inhibitor that has been used in clinics for other diseases. This study opens a new window to target the SRC signaling activity which is antagonized by THY1 in NPC. We had previously shown that THY1 (CD90) is a tumor suppressor in nasopharyngeal carcinoma (NPC) and that its down-regulation and loss of expression are associated with tumor metastasis, yet the mechanism leading to such effects remains unknown. In this study we show that tumor invasion could be suppressed by THY1 via adherens junction formation in a few NPC cell lines, and knockdown of THY1 would disrupt this cell-cell adhesion phenotype. Mechanistically, the activity of the SRC family kinase (SFK) member, SRC, and canonical Wnt signaling were dramatically reduced when THY1 was constitutively expressed. Previous studies by others have found that high levels of SRC activity in NPCs are associated with EMT and a poor prognosis. We hypothesized that THY1 can suppress tumor invasion in NPC via inhibition of SRC. By gene silencing of SRC, we found that the in vitro NPC cell invasion was significantly reduced and adherens junctions were restored. Through proteomic analysis, we identified that platelet-derived growth factor receptor β (PDGF-Rβ) and protein tyrosine phosphatase nonreceptor type 22 (PTPN22) are novel and potential binding partners of THY1, which were subsequently verified by co-immunoprecipitation (co-IP) analysis. The ligand of PDGF-Rβ (PDGF-BB) could highly induce SRC activation and NPC cell invasion, which could be almost completely suppressed by THY1 expression. On the other hand, the PTPN22 siRNA could enhance both the SRC activities and the cell invasion and could also disrupt the adherens junctions in the THY1-expressing NPC cells; the original THY1-induced phenotypes were reverted when the PTPN22 expression was reduced. Together, our results identified that PTPN22 is essential for THY1 to suppress cell invasion and SRC activity, maintain tight adherens junctions, and prevent NPC metastasis. These results suggested that PDGF-Rβ and SRC can be used as drug targets for suppressing NPC metastasis. Indeed, our in vivo assay using the SRC inhibitor KX2-391, clearly showed that inhibition of SRC signaling can prevent the metastasis of NPC, indicating that targeting SRC can be a promising approach to control the NPC progression. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Flexible Cyclic Immunofluorescence (cyCIF) Using Oligonucleotide Barcoded Antibodies.
- Author
-
McMahon, Nathan P., Jones, Jocelyn A., Anderson, Ashley N., Dietz, Matthew S., Wong, Melissa H., and Gibbs, Summer L.
- Subjects
IMMUNOGLOBULINS ,ANIMAL experimentation ,NUCLEOTIDES ,FLUORESCENT antibody technique ,LIGHT ,RESEARCH funding ,TUMOR markers ,MICE ,ANTIGENS - Abstract
Simple Summary: Advances in our understanding of the complex spatial interactions between tumor epithelia and tumor microenvironmental cells have been driven by highly multiplexed imaging technologies. These techniques are capable of labeling many more biomarkers than conventional immunostaining methods. However, multiplexed imaging techniques suffer from low detection sensitivity, cell loss—particularly in fragile samples—and challenges with antibody labeling. Herein, we developed and optimized a DNA antibody barcoding strategy for cyclic immunofluorescence (cyCIF) that can be amplified to increase the detection efficiency of low-abundance antigens. Stained fluorescence signals can be readily removed using ultraviolet light treatment, preserving tissue and fragile cell sample integrity. Advances in our understanding of the complex, multifaceted interactions between tumor epithelia, immune infiltrate, and tumor microenvironmental cells have been driven by highly multiplexed imaging technologies. These techniques are capable of labeling many more biomarkers than conventional immunostaining methods. However, multiplexed imaging techniques suffer from low detection sensitivity, cell loss—particularly in fragile samples—, and challenges with antibody labeling. Herein, we developed and optimized an oligonucleotide antibody barcoding strategy for cyclic immunofluorescence (cyCIF) that can be amplified to increase the detection efficiency of low-abundance antigens. Stained fluorescence signals can be readily removed using ultraviolet light treatment, preserving tissue and fragile cell sample integrity. We also extended the oligonucleotide barcoding strategy to secondary antibodies to enable the inclusion of difficult-to-label primary antibodies in a cyCIF panel. Using both the amplification oligonucleotides to label DNA barcoded antibodies and in situ hybridization of multiple fluorescently labeled oligonucleotides resulted in signal amplification and increased signal-to-background ratios. This procedure was optimized through the examination of staining parameters including staining oligonucleotide concentration, staining temperature, and oligonucleotide sequence design, resulting in a robust amplification technique. As a proof-of-concept, we demonstrate the flexibility of our cyCIF strategy by simultaneously imaging with the original oligonucleotide conjugated antibody (Ab-oligo) cyCIF strategy, the novel Ab-oligo cyCIF amplification strategy, as well as direct and indirect immunofluorescence to generate highly multiplexed images. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
- Author
-
Rekstin, Andrey, Isakova-Sivak, Irina, Petukhova, Galina, Korenkov, Daniil, Losev, Igor, Smolonogina, Tatiana, Tretiak, Tatiana, Donina, Svetlana, Shcherbik, Svetlana, Bousse, Tatiana, and Rudenko, Larisa
- Subjects
- *
PREVENTION of epidemics , *INFLUENZA prevention , *ANIMAL experimentation , *ANTIGENS , *BIOLOGICAL assay , *DYNAMICS , *ENZYME-linked immunosorbent assay , *FLOW cytometry , *GENETIC techniques , *GLYCOSIDASES , *IMMUNOGLOBULINS , *IMMUNOLOGICAL adjuvants , *INFLUENZA vaccines , *MICE , *NUCLEIC acids , *PROBABILITY theory , *PROTEINS , *RESEARCH funding , *T cells , *TOXICITY testing , *DRUG development , *INFLUENZA A virus, H1N1 subtype , *DATA analysis software , *DESCRIPTIVE statistics , *IN vitro studies , *MANN Whitney U Test , *KRUSKAL-Wallis Test , *IN vivo studies - Abstract
Since conserved viral proteins of influenza virus, such as nucleoprotein (NP) and matrix 1 protein, are the main targets for virus-specific CD8+ cytotoxic T-lymphocytes (CTLs), we hypothesized that introduction of the NP gene of wild-type virus into the genome of vaccine reassortants could lead to better immunogenicity and afford better protection. This paper describes in vitro and in vivo preclinical studies of two new reassortants of pandemic H1N1 live attenuated influenza vaccine (LAIV) candidates. One had the hemagglutinin (HA) and neuraminidase (NA) genes from A/South Africa/3626/2013 H1N1 wild-type virus on the A/Leningrad/134/17/57 master donor virus backbone (6 : 2 formulation) while the second had the HA, NA, and NP genes of the wild-type virus on the same backbone (5 : 3 formulation). Although both LAIVs induced similar antibody immune responses, the 5 : 3 LAIV provoked greater production of virus-specific CTLs than the 6 : 2 variant. Furthermore, the 5 : 3 LAIV-induced CTLs had higher in vivo cytotoxic activity, compared to 6 : 2 LAIV. Finally, the 5 : 3 LAIV candidate afforded greater protection against infection and severe illness than the 6 : 2 LAIV. Inclusion in LAIV of the NP gene from wild-type influenza virus is a new approach to inducing cross-reactive cell-mediated immune responses and cross protection against pandemic influenza. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti.
- Author
-
Cornillot, Emmanuel, Dassouli, Amina, Pachikara, Niseema, Lawres, Lauren, Renard, Isaline, Francois, Celia, Randazzo, Sylvie, Brès, Virginie, Garg, Aprajita, Brancato, Janna, Pazzi, Joseph E., Pablo, Jozelyn, Hung, Chris, Teng, Andy, Shandling, Adam D., Huynh, Vu T., Krause, Peter J., Lepore, Timothy, Delbecq, Stephane, and Hermanson, Gary
- Subjects
ANTIGENS ,PATHOGENIC microorganisms ,BABESIA ,DONOR blood supply ,BLOOD transfusion ,ANIMAL experimentation ,BABESIOSIS ,DYNAMICS ,GENOMES ,MICE ,PROTOZOA ,RESEARCH funding ,PROTEIN microarrays - Abstract
Background: Babesia microti is a protozoan parasite responsible for the majority of reported cases of human babesiosis and a major risk to the blood supply. Laboratory screening of blood donors may help prevent transfusion-transmitted babesiosis but there is no Food and Drug Administration-approved screening method yet available. Development of a sensitive, specific, and highly automated B. microti antibody assay for diagnosis of acute babesiosis and blood screening could have an important impact on decreasing the health burden of B. microti infection.Study Design and Methods: Herein, we take advantage of recent advances in B. microti genomic analyses, field surveys of the reservoir host, and human studies in endemic areas to apply a targeted immunomic approach to the discovery of B. microti antigens that serve as signatures of active or past babesiosis infections. Of 19 glycosylphosphatidylinositol (GPI)-anchored protein candidates (BmGPI1-19) identified in the B. microti proteome, 17 were successfully expressed, printed on a microarray chip, and used to screen sera from uninfected and B. microti-infected mice and humans to determine immune responses that are associated with active and past infection.Results: Antibody responses to various B. microti BmGPI antigens were detected and BmGPI12 was identified as the best biomarker of infection that provided high sensitivity and specificity when used in a microarray antibody assay.Conclusion: BmGPI12 alone or in combination with other BmGPI proteins is a promising candidate biomarker for detection of B. microti antibodies that might be useful in blood screening to prevent transfusion-transmitted babesiosis. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
12. The Immunoregulatory Effect of Aconite Treatment on H22 Tumor-Bearing Mice via Modulating Adaptive Immunity and Natural Killer-Related Immunity.
- Author
-
Wang, Huan, Qi, Xiu zhong, Jia, Wentao, Yu, Jiahui, Yang, Kangdi, Zhang, Xu, and Wang, Lina
- Subjects
ACONITE ,HERBAL medicine ,ANIMAL experimentation ,KILLER cells ,ANTINEOPLASTIC agents ,CELL receptors ,CANCER patients ,INTERFERONS ,IMMUNITY ,DOSE-effect relationship in pharmacology ,RESEARCH funding ,GLYCOPROTEINS ,T cells ,TUMOR markers ,MEMBRANE proteins ,HEPATOCELLULAR carcinoma ,CHINESE medicine ,MICE ,ANTIGENS ,PHARMACODYNAMICS ,DRUG administration ,DRUG dosage - Abstract
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and, in its advanced stages, has a 5-year survival rate of only 3% to 5%. Despite novel mechanisms and treatments being uncovered over the past few years, effective strategies for HCC are currently limited. Previous studies have proven that aconite can suppress tumor growth and progression and prevent the recurrence and metastasis of multiple cancers, but the underlying molecular mechanisms are largely unknown. In this study, different doses of aconite were applied to mice bearing subcutaneous HCC tumors. It was found that aconite had a therapeutic effect on H22 tumor-bearing mice in a dose-dependent manner by reducing tumor volumes and prolonging survival times, which could be attributed to the immunoregulatory effect of aconite. Furthermore, results showed that high-dose administration of aconite could enhance adaptive immunity and natural killer (NK) cell-mediated immunity by regulating the secretion of interferon-γ, upregulating T cells and NK cells, and modulating the expression of the NK cytotoxicity biomarker CD107a and the inhibitory receptor TIGIT. This study revealed a novel mechanism through which aconite exerts antitumor effects, not merely through apoptosis induction pathways, providing more sound evidence that aconite has the potential to be developed into an effective anti-HCC agent. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma.
- Author
-
Kikuchi, Hiroto, Matsui, Aya, Morita, Satoru, Amoozgar, Zohreh, Inoue, Koetsu, Ruan, Zhiping, Staiculescu, Daniel, Wong, Jeffrey Sum-Lung, Huang, Peigen, Yau, Thomas, Jain, Rakesh K, and Duda, Dan G
- Subjects
LIVER tumors ,NEOVASCULARIZATION inhibitors ,ANIMAL experimentation ,RESEARCH funding ,T cells ,VASCULAR endothelial growth factors ,HEPATOCELLULAR carcinoma ,MICE ,ANTIGENS - Abstract
Immune checkpoint blockade combined with antiangiogenic therapy induces vascular normalization and antitumor immunity and is efficacious in hepatocellular carcinoma (HCC); but whether and how initial immunotherapy affects the efficacy of subsequent antiangiogenic therapy are unknown. We evaluated a cohort of HCC patients (n = 25) who received the pan-vascular endothelial growth factor receptor multikinase inhibitor sorafenib after initial therapy with an antiprogrammed cell death protein (PD)-1 antibody and found superior outcomes in these patients (12% overall response rate to sorafenib and a median overall survival of 12.1 months). To prove this potential benefit, we examined the impact of an anti-PD-1 antibody on response to subsequent sorafenib treatment in orthotopic models of murine HCC. Prior anti-PD-1 antibody treatment amplified HCC response to sorafenib therapy and increased survival (n = 8-9 mice per group, hazard ratio = 0.28, 95% confidence interval = 0.09 to 0.91; 2-sided P = .04). Anti-PD-1 therapy showed angioprotective effects on HCC vessels to subsequent sorafenib treatment, which enhanced the benefit of this therapy sequence in a CD8+ T-cell-dependent manner. This priming approach using immunotherapy provides an immediately translatable strategy for effective HCC treatment while reducing drug exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. GROWTH PERFORMANCE OF GOATS IMMUNIZED WITH THORAXIAL ANTIGENS OF MUSCA DOMESTICA.
- Author
-
RUMOKOY, Laurentius, RUMAMBI, Agnitje, WAANI, Merci Rosyanty, and TOAR, Wisje Lusia
- Subjects
- *
HOUSEFLY , *ANTIGENS , *WEIGHT gain , *BODY weight , *ANIMAL experimentation , *GOATS - Abstract
The antigen thoraxial extracted from some insects indicated a potential in immunity system amelioration in mammalian. This study aimed to evaluate the growth performance of goats immunized with IATMd (immunogen antigens of Musca domestica). Twelve goats were used in this experiment. Each experiment animal was treated with 10 µl of thoraxial antigens of Musca domestica. The animals were divided into two groups: control group and treated group. The growth performances were evaluated under three parameters: Body weight gain, feed intake and FCR. All animals were fed with the same feed. The data were collected during eight weeks and analyzed by using t-student procedure. The results showed that FCR of the animas in treatment group was significance higher than in the control group (P<0.05) while there has no different statistically on body weight gain (P>0.05). It was concluded that immunization of IATMd extract could improve nutrient metabolism in goats that play a role in FCR value of these animals experiment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
15. Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy.
- Author
-
Liu, Chenglong, Zhou, Feilong, Yan, Ziqin, Shen, Lian, Zhang, Xichen, He, Fenglian, Wang, Heng, Lu, Xiaojie, Yu, Ker, Zhao, Yujun, and Zhu, Di
- Subjects
PROGRAMMED death-ligand 1 ,PROGRAMMED cell death 1 receptors ,BIOMARKERS ,TUMOR microenvironment ,LABORATORY mice ,LEAD compounds ,RESEARCH ,ANIMAL experimentation ,RESEARCH methodology ,CELL physiology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,TUMORS ,IMMUNOTHERAPY ,MICE ,ANTIGENS - Abstract
Background and Purpose: PD-1/PD-L1 antibodies have achieved great success in clinical treatment. However, monoclonal antibody drugs also have challenges, such as high manufacturing costs, poor diffusion, low oral bioavailability and limited penetration into tumour tissue. The development of small-molecule inhibitors of PD-1/PD-L1 interaction represents a promising perspective to overcome the above challenges in cancer immunotherapy.Experimental Approach: We explored structural activity relationships and used biochemical assays to generate a lead compound (ZE132). CD8+ T-cells killing assay and Ifng expression assay were used to verify the in vitro cellular activity of ZE132. Off-target study was performed to verify the selectivity. Syngeneic mouse models were used to verify the in vivo activity of ZE132 in tumour immune microenvironment (TIME). We also performed pharmacokinetics profiling in mice and The Cancer Genome Atlas database analysis.Key Results: ZE132 can effectively inhibit the PD-1/PD-L1 interactions in vitro, and it has a potent affinity to PD-L1. ZE132 shows robust anti-tumour effects in vivo, better than anti-PD-1 antibody. In the analysis of TIME, we found that ZE132 treatment promotes cytotoxic T-cell tumour infiltration and induces IL-2 expression. In addition, ZE132 elicits strong inhibitory effects on the mRNA expression of TGF-β, which may serve as a potential biomarker to predict responsiveness to PD-1/PD-L1 immunotherapies.Conclusion and Implications: We identified a new lead compound ZE132 targeting PD-1/PD-L1 interactions, not only showing favourable drug-like properties in vitro and in vivo but also showing the advantage of overcoming the barrier of TIME compared to anti-PD-1 antibody. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
16. Promotion of Differentiating Bone Marrow Mesenchymal Stromal Cells (BMSCs) into Cardiomyocytes via HCN2 and HCN4 Cotransfection.
- Author
-
Luo, Xue, Li, Hongxiao, Sun, Xiaolin, Zuo, Qisheng, Li, Bichun, Zhu, Ye, Wei, Wei, and Gu, Xiang
- Subjects
CELL differentiation ,FLOW cytometry ,STAINS & staining (Microscopy) ,ANIMAL experimentation ,WESTERN immunoblotting ,SWINE ,GENE expression ,STEM cells ,FLUORESCENT antibody technique ,DESCRIPTIVE statistics ,BONE marrow ,MEMBRANE proteins ,ANTIGENS - Abstract
Aim. Investigation of the influences HCN2 and HCN4 has on bone marrow mesenchymal stromal cells (BMSCs) on cardiomyocyte differentiation. Methods. Miniature adult pigs were used for bone marrow extraction and isolation of BMSCs. The identification of these BMSCs was done by using flow cytometry for the detection of expressed surface antigens CD45, CD11B, CD44, and CD90. Using HCN2 and HCN4 genes cotransfected into BMSCs as group HCN2+HCN4 while myocardial induction solution was used to induced BMSC differentiation in the BMSC induction group. Myocardial marker proteins α-actin and cTnT were detected by immunofluorescence staining, while α-actin, cTnT, and Desmin myocardial marker proteins expressed were detected by Western blot. The whole-cell patch-clamp technique was used to identify and detect cellular HCN2 channels, HCN4 channel current activation curve, and the inhibitory effect of CsCl on heterologous expression currents. Results. Flow cytometry results showed that CD45 and CD11B were expressed negatively while CD90 and CD44 were positive. Post HCN2 and HCN4 gene transfection, immunofluorescence staining, and Western blot showed significantly increased HCN2, HCN4, α-actin, and cTnT expressed in group HCN2+HCN4 were, which could be compared to the expression levels in the BMSC-induced group. The HCN2+HCN4 group was able to document cell membrane channel ion currents that were similar to If properties. Conclusion. HCN2 and HCN4 overexpression can considerably enhance the MSC ability to differentiate into cardiomyocytes in vitro and restore the ionic current. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.
- Author
-
Ratnapriya, Sneha, Keerti, Yadav, Narendra Kumar, Dube, Anuradha, and Sahasrabuddhe, Amogh Anant
- Subjects
IMMUNOGLOBULIN analysis ,HAMSTERS ,INTERLEUKINS ,LEISHMANIASIS ,VACCINES ,ANIMAL experimentation ,INTERFERONS ,BCG vaccines ,TUMOR necrosis factors ,RECOMBINANT proteins ,ANTIGENS - Abstract
Immunotherapy, a treatment based on host immune system activation, has been shown to provide a substitute for marginally effective conventional chemotherapy in controlling visceral leishmaniasis (VL), the deadliest form of leishmaniasis. As the majority of endemic inhabitants exhibit either subclinical or asymptomatic infection which often develops into the active disease state, therapeutic intervention seems to be an important avenue for combating infections by stimulating the natural defense system of infected individuals. With this perspective, the present study focuses on two immunodominant Leishmania (L.) donovani antigens (triosephosphate isomerase and enolase) previously proved to be potent prophylactic VL vaccine candidates, for generating a recombinant chimeric antigen. This is based on the premise that in a heterogeneous population, a multivalent antigen vaccine would be required for an effective response against leishmaniasis (a complex parasitic disease). The resulting molecule rLdT-E chimeric protein was evaluated for its immunogenicity and immunotherapeutic efficacy. A Th1 stimulating adjuvant BCG was employed with the protein which showed a remarkable 70% inhibition of splenic parasitic multiplication positively correlated with boosted Th1 dominant immune response against lethal L. donovani challenge in hamsters as evidenced by high IFN-γ and TNF-α and low IL-10. In addition, immunological analysis of antibody subclass presented IgG2-based humoral response besides considerable delayed-type hypersensitivity and lymphocyte proliferative responses in rLdT-E/BCG-treated animals. Our observations indicate the potential of the chimera towards its candidature for an effective vaccine against Leishmania donovani infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy.
- Author
-
Dong, Zhaocheng, Liu, Zhiyuan, Dai, Haoran, Liu, Wenbin, Feng, Zhendong, Zhao, Qihan, Gao, Yu, Liu, Fei, Zhang, Na, Dong, Xuan, Zhou, Xiaoshan, Du, Jieli, Huang, Guangrui, Tian, Xuefei, and Liu, Baoli
- Subjects
REGULATORY B cells ,HUMORAL immunity ,KIDNEY diseases ,T cells ,HUMAN body ,KIDNEY glomerulus diseases ,CYTOKINES ,AUTOANTIBODIES ,IMMUNOGLOBULINS ,ANIMAL experimentation ,ARTHRITIS Impact Measurement Scales ,IMMUNOLOGY technique ,CELL communication ,PSYCHOLOGICAL tests ,DISEASE susceptibility ,IMMUNITY ,GLOMERULONEPHRITIS ,PSYCHOLOGICAL adaptation ,ANTIGENS - Abstract
Regulatory B cells (Breg) are widely regarded as immunomodulatory cells which play an immunosuppressive role. Breg inhibits pathological autoimmune response by secreting interleukin-10 (IL-10), transforming growth factor-β (TGF-β), and adenosine and through other ways to prevent T cells and other immune cells from expanding. Recent studies have shown that different inflammatory environments induce different types of Breg cells, and these different Breg cells have different functions. For example, Br1 cells can secrete IgG4 to block autoantigens. Idiopathic membranous nephropathy (IMN) is an autoimmune disease in which the humoral immune response is dominant and the cellular immune response is impaired. However, only a handful of studies have been done on the role of Bregs in this regard. In this review, we provide a brief overview of the types and functions of Breg found in human body, as well as the abnormal pathological and immunological phenomena in IMN, and propose the hypothesis that Breg is activated in IMN patients and the proportion of Br1 can be increased. Our review aims at highlighting the correlation between Breg and IMN and proposes potential mechanisms, which can provide a new direction for the discovery of the pathogenesis of IMN, thus providing a new strategy for the prevention and early treatment of IMN. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Glycine Receptor Autoantibodies Impair Receptor Function and Induce Motor Dysfunction.
- Author
-
Rauschenberger, Vera, von Wardenburg, Niels, Schaefer, Natascha, Ogino, Kazutoyo, Hirata, Hiromi, Lillesaar, Christina, Kluck, Christoph J., Meinck, Hans‐Michael, Borrmann, Marc, Weishaupt, Andreas, Doppler, Kathrin, Wickel, Jonathan, Geis, Christian, Sommer, Claudia, Villmann, Carmen, and Meinck, Hans-Michael
- Subjects
GLYCINE receptors ,MYOCLONUS ,AUTOANTIBODIES ,N-terminal residues ,ANIMAL behavior ,RADIOLIGAND assay ,ENCEPHALITIS ,RESEARCH ,ANIMAL experimentation ,RESEARCH methodology ,CELL receptors ,EVALUATION research ,MEDICAL cooperation ,COMPARATIVE studies ,MUSCLE rigidity ,FISHES ,RESEARCH funding ,STIFF-person syndrome ,ANTIGENS - Abstract
Objective: Impairment of glycinergic neurotransmission leads to complex movement and behavioral disorders. Patients harboring glycine receptor autoantibodies suffer from stiff-person syndrome or its severe variant progressive encephalomyelitis with rigidity and myoclonus. Enhanced receptor internalization was proposed as the common molecular mechanism upon autoantibody binding. Although functional impairment of glycine receptors following autoantibody binding has recently been investigated, it is still incompletely understood.Methods: A cell-based assay was used for positive sample evaluation. Glycine receptor function was assessed by electrophysiological recordings and radioligand binding assays. The in vivo passive transfer of patient autoantibodies was done using the zebrafish animal model.Results: Glycine receptor function as assessed by glycine dose-response curves showed significantly decreased glycine potency in the presence of patient sera. Upon binding of autoantibodies from 2 patients, a decreased fraction of desensitized receptors was observed, whereas closing of the ion channel remained fast. The glycine receptor N-terminal residues 29 A to 62 G were mapped as a common epitope of glycine receptor autoantibodies. An in vivo transfer into the zebrafish animal model generated a phenotype with disturbed escape behavior accompanied by a reduced number of glycine receptor clusters in the spinal cord of affected animals.Interpretation: Autoantibodies against the extracellular domain mediate alterations of glycine receptor physiology. Moreover, our in vivo data demonstrate that the autoantibodies are a direct cause of the disease, because the transfer of human glycine receptor autoantibodies to zebrafish larvae generated impaired escape behavior in the animal model compatible with abnormal startle response in stiff-person syndrome or progressive encephalitis with rigidity and myoclonus patients. ANN NEUROL 2020;88:544-561. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
20. Yangjing Capsule Can Improve the Function of the Testicular Angiogenesis through Activating VEGFA/eNOS Signaling Pathway.
- Author
-
Jin, Baofang, Sun, Dalin, Dong, Weihang, Chen, Bing, Deng, Weimin, Cai, Bin, Cui, Yugui, Jin, Yihan, Liu, Jianguo, Tong, Li, and Wu, Ping
- Subjects
ANIMAL experimentation ,ANTIGENS ,PHARMACEUTICAL encapsulation ,CELLULAR signal transduction ,ENDOTHELIUM ,GENE expression ,HERBAL medicine ,CHINESE medicine ,MICE ,SPERMATOZOA ,TESTIS ,TESTICULAR diseases ,NITRIC-oxide synthases ,VASCULAR endothelial growth factors ,CYCLOPHOSPHAMIDE ,PATHOLOGIC neovascularization ,DRUG administration ,DRUG dosage ,PHARMACODYNAMICS - Abstract
Background. The testicular microcirculation was an important aspect of testicular physiology and it offered a stable environment for the transport of nutrients and secretary products in the testis. Yangjing capsule (YC), a traditional Chinese compound herbal prescription, has been proved as an effective drug to ameliorate spermatogenesis, promote testosterone synthesis in vivo, and cure spermatogenesis in clinical practice. Objective. This study was aimed at understanding the potential mechanisms of YC exerting angiogenic effects in the mouse spermatogenesis dysfunction model induced by cyclophosphamide (CP) and MLTC-1 cells. Materials and Methods. Balb/c mice were randomly divided into five groups: control, CP, CP plus YC (630 mg/kg), CP plus YC (1260 mg/kg), and CP plus YC (2520 mg/kg). After 30 days, mice were sacrificed and the expressions of endothelial marker CD34+, angiogenic marker VEGFA, VEGFR1, VEGFR2, and eNOS in the testes of the mice were examined; moreover, Leydig cell line MLTC-1 cells were cultured and treated with different concentrations of YC extracts (YCE), and the expressions of VEGFA, VEGFR1, VEGFR2, and eNOS, as well as the secretion of NO, were evaluated. Results. We observed that YC significantly increased the expressions of VEGFA, VEGFR1, VEGFR2, and eNOS in testes of CP-treated mice; moreover, YCE has led to increased expressions of VEGFA, VEGFR1, VEGFR2, and eNOS and secretion of NO in MLTC-1 in vitro. These data suggested that the YC might be an alternative treatment for the dysfunction of testicular microcirculation by promoting the angiogenesis in the testis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Quercitrin, the Main Compound in Wikstroemia indica, Mitigates Skin Lesions in a Mouse Model of 2,4-Dinitrochlorobenzene-Induced Contact Hypersensitivity.
- Author
-
Jegal, Jonghwan, Park, No-June, Lee, So-Yeon, Jo, Beom-Geun, Bong, Sim-Kyu, Kim, Su-Nam, and Yang, Min Hye
- Subjects
ANIMAL experimentation ,ANTIGENS ,BIOMARKERS ,CONTACT dermatitis ,ETHANOL ,MICE ,MOLECULAR structure ,QUERCETIN ,SKIN diseases ,PLANT extracts ,TREATMENT effectiveness ,DESCRIPTIVE statistics - Abstract
Hapten-induced contact hypersensitivity (CHS) is widely utilized to induce immune activation in animal models of allergic contact dermatitis. Our previous findings suggested that the 95% EtOH extract of Wikstroemia indica (L.) C. A. Mey. has antiallergic and anti-inflammatory effects in DNCB-treated CHS SKH-1 hairless mice. The aim of this study was to evaluate the protective effects of compounds isolated from the EtOAc fraction of W. indica in RBL-2H3 cells and 2,4-dinitrochlorobenzene- (DNCB-) induced CHS mice. Of eight compounds in W. indica, that is, umbelliferone, daphnoretin, wikstrocoumarin, (+)-syringaresinol, tricin, (+)-lariciresinol, erythro-guaiacylglycerol- β -coniferyl ether, and quercitrin, quercitrin exhibited the most antiallergic activity against antigen-induced β -hexosaminidase release and IL-4 mRNA expression, which are markers of degranulation in RBL-2H3 cells. After a 7-sensitizing period, 14 days of DNCB treatment with or without topical pimecrolimus (1%) or quercitrin (0.5%) treatment, quercitrin was found to suppress DNCB-induced increases in serum IL-4 and IgE concentrations and transepidermal water loss. These results indicate that quercitrin has therapeutic potential for treatment of allergies and allergy-related contact dermatitis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. The Effect of Competitive Antigen on Some Cytokine in Rabbits.
- Author
-
Neama, Aseel Hashim, Shnawa, Ibrahim M. S., and Abd, Frial G.
- Subjects
CYTOKINES ,ESCHERICHIA coli ,BIOLOGICAL models ,INTERLEUKINS ,IMMUNIZATION ,ANIMAL experimentation ,RABBITS ,MEDICAL protocols ,TUMOR necrosis factors ,ENZYME-linked immunosorbent assay ,DESCRIPTIVE statistics ,PSEUDOMONAS ,ANTIGENS - Abstract
Bacterin can be divided into dead bacterin and live bacterin. Dead bacterin is a virulent strains which have a good immunogenicity the aim of this study to know competitive between two bacterin E.coli and P.aeruginosa in different concentrations .The rabbits were used as model for this study and the rabbits were divided into six groups each groups composed 5 rabbits. After immunized programs the blood were collected. The sera were separated and used to determine TNF-α, IL-2 and IL-10 by enzyme linked immunosorbent assay the results appeared. The results appeared different count of bacteria increased (54.09, 68.33) TNF-α compared with control (42.55) the concentrations of IL-2 were increased with increased dose of E.coli (16.90, 20.29) also the same occurred with P.aeruginosa (in P aeruginosa alone was15.14 while combined with E.coli 15.56 and15.38, the results appeared the means of IL-2 concentrations were higher, Interleukin 10 were showed its mean was increased in same concentrations of bacterin but decreased in different count. The present findings seems to be novel since combined bacterins have the potential for use as an autogenous bacterins in therapy for cases of complicated multi-drug resistant infections like that of urinary tract. [ABSTRACT FROM AUTHOR]
- Published
- 2020
23. Characterization and anti-uterine tumor effect of extract from Prunella vulgaris L.
- Author
-
Lin, Yan, Yang, Chao, Tang, Jie, Li, Chun, Zhang, Zhi-min, Xia, Bo-hou, Li, Ya-mei, He, Qing-zhi, Lin, Li-mei, and Liao, Duan-fang
- Subjects
FATTY acid analysis ,HYDROCARBON analysis ,CELL proliferation ,ANIMAL experimentation ,ANTIGENS ,APOPTOSIS ,CELL cycle ,CELL lines ,CELLULAR signal transduction ,ENZYME-linked immunosorbent assay ,ESTROGEN ,FLOW cytometry ,GAS chromatography ,GENE expression ,MASS spectrometry ,MITOCHONDRIA ,MUSCLE tumors ,ONCOGENES ,POLYENES ,PROGESTERONE ,RATS ,TUMOR classification ,UNSATURATED fatty acids ,UTERINE tumors ,LINOLEIC acid ,PLANT extracts ,CASPASES ,IN vitro studies ,CELL cycle proteins - Abstract
Background: The flowers and dried fruit spikes of Prunella vulgaris L. (P. vulgaris L.) have been widely used in traditional Chinese medicine and food. P. vulgaris L. is regarded as a good option for treating uterine myoma (UM). However, scientific evidence of anti-UM activity of the extract of P. vulgaris L. (PVE) is lacking. The present study aimed to characterize the chemical composition of PVE and evaluate the pharmacodynamics and mechanism of PVE against UM. Methods: The chemical composition of PVE was analyzed by GC-MS. MTT was used to screen and evaluate cell proliferation and toxicity. Double fluorescence flow cytometry method were used to determine the apoptosis and cell cycle progression of UM cells under PVE treatment. The anti-UM activity of PVE was investigated by using a specific-pathogen-free (SPF) rat model of UM. TUNEL staining was used to detect the apoptosis of UM cells. The concentrations of estrogen and progesterone in the serum of SPF rats were detected by ELISA. The expression levels of PCNA, estrogen receptor alpha, estrogen receptor beta, progesterone receptor, survivin, caspase-3, Bax and Bcl-2 in the uterus of SPF rats was detected by immunohistochemistry (IHC). Results: The extraction rate of PVE was 8.1%. The main components were squalene (28.3%), linoleic acid (9.96%), linolenic acid (9.95%), stearic acid (6.26%) and oleic acid (5.51%). In vitro, PVE had significant anti-human UM cell activity, exhibited no drug toxicity, promoted the apoptosis of human UM cells, and inhibited the transition of UM cells from the G0/G1 stage into the G2 stage, in which DNA replication occurs. In vivo, PVE had significant anti-UM activity. PVE decreased the concentrations of estrogen and progesterone and downregulated the expression levels of the estrogen and progesterone receptors through the estrogen signaling pathway. PVE also promoted the apoptosis of UM cells by downregulating the expression levels of the survivin and Bcl-2 proteins and upregulating the expression levels of caspase-3 and Bax through the mitochondria-mediated apoptotic pathway. Conclusion: PVE has marked anti-UM activity. PVE can be used as an ideal candidate drug to treat UM. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Vaccines targeting the primary amino acid sequence and conformational epitope of amyloid-β had distinct effects on neuropathology and cognitive deficits in EAE/AD mice.
- Author
-
Yu, Xiao‐Lin, Zhu, Jie, Liu, Xiang‐meng, Xu, Peng‐xin, Zhang, Yue, Liu, Rui‐tian, Yu, Xiao-Lin, Liu, Xiang-Meng, Xu, Peng-Xin, and Liu, Rui-Tian
- Subjects
AMYLOID plaque ,AMINO acid sequence ,AMYLOID beta-protein precursor ,AMYLOID beta-protein ,VACCINATION complications ,ALZHEIMER'S disease ,MICE ,BIOLOGICAL models ,RESEARCH ,VACCINES ,DEMYELINATION ,ANIMAL experimentation ,RESEARCH methodology ,PROTEIN precursors ,COGNITION ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,AMINO acids ,ANTIGENS ,PEPTIDES - Abstract
Background and Purpose: Immunotherapeutic intervention is one of the most promising strategies for the prevention and treatment of Alzheimer's disease (AD). Although they showed great success in AD mouse models, the clinical trials of many immune approaches failed due to low efficacy and safety. Thus, an animal model which can show the potential side effects of vaccines or antibodies is urgently needed. In this study, we generated EAE/AD mice by crossing APP/PS1 mice with experimental autoimmune encephalomyelitis (EAE) mice. We then investigated the efficacy and safety of two vaccines: the immunogens of which were Aβ1-42 aggregates (Aβ42 vaccine) and an oligomer-specific conformational epitope (AOE1 vaccine), respectively.Experimental Approach: EAE/AD mice were immunized with the Aβ42 vaccine or AOE1 vaccine five times at biweekly intervals. After the final immunization, cognitive function was evaluated by the Morris water maze, Y maze, and object recognition tests. Neuropathological changes in the mouse brains were analysed by immunohistochemistry and ELISA.Key Results: In contrast to previous findings in conventional AD animal models, Aβ42 immunization promoted neuroinflammation, enhanced Aβ levels and plaque burden, and failed to restore cognitive deficits in EAE/AD mice. By contrast, AOE1 immunization dramatically attenuated neuroinflammation, reduced Aβ levels, and improved cognitive performance in EAE/AD mice.Conclusion and Implications: These results suggest that the EAE/AD mouse model can exhibit the potential side effects of AD immune approaches that conventional AD animal models fail to display. Furthermore, strategies specifically targeting Aβ oligomers may be safe and show clinical benefit for AD treatment. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
25. Relative Resilience of Cerebellar Purkinje Cells in a Cardiac Arrest/Resuscitation Rat Model.
- Author
-
Keilhoff, Gerburg, Nguyen Thi, Tue Minh, Esser, Torben, and Ebmeyer, Uwe
- Subjects
PURKINJE cells ,HEART cells ,CALBINDIN ,CARDIAC arrest ,CELL death ,PYRAMIDAL neurons ,PROTEIN metabolism ,CARDIOPULMONARY resuscitation ,BIOLOGICAL models ,ALBUMINS ,NEURONS ,HIPPOCAMPUS (Brain) ,NERVE tissue proteins ,ANIMAL experimentation ,MICROFILAMENT proteins ,CYTOSKELETAL proteins ,SUPEROXIDE dismutase ,RATS ,CEREBELLUM ,CALCIUM-binding proteins ,ANTIGENS - Abstract
Background: In studies on cardiac arrest (CA)/resuscitation (R) injury, Purkinje cell degeneration was described, however, with inconsistent data concerning severity and time point of manifestation. Moreover, CA/R studies paid only limited attention to inhibitory stellate interneurons. To this aim, the hypothesis that cerebellar could be relatively resilient toward CA/R because of diverse cellular defense mechanisms including interaction with stellate cells was tested.Methods: We examined rats with survival times of 6, 24, and 48 h, and 7 and 21 days in comparison with sham- and nonoperated animals. Thereby, we focused on the immunohistochemical expression of cfos, MnSOD, Bcl2, caspase 3, parvalbumin, calbindin D28 k, MAP2, IBA1, and GFAP, especially in the particular sensitivity to CA/R cerebellar lobule IX. Hippocampal CA1 degeneration was demonstrated by expression patterns of MAP2 and NeuN in combination with IBA1 and GFAP.Results/conclusions: Comparative analysis of hippocampal CA1 pyramidal cells and cerebellar Purkinje cells confirmed a relative resil-ience of Purkinje cells to CA/R. We found only a notable degeneration of Purkinje cell neuronal fiber network, which, however, not necessarily led to neuronal cell death. To induce significant Purkinje cell loss, a stronger ischemic trigger seems to be needed. As possible Purkinje cell-protecting mechanisms, we would propose: (1) activation of inhibitory stellate cells, shown by cfos, MnSOD, and Bcl2 expression, balancing out ischemia-induced excitation and inhibition of Purkinje cells; (2) translocation of the calcium-buffering system, shown by parvalbumin and calbindin D28 k expression, protecting Purkinje cells from detrimental calcium overload; (3) activation of the neuron-astrocyte cross talk, protecting Purkinje cells from over-excitation by removing potassium and neurotransmitters from the extracellular space; (4) activation of the effective and long-lasting MnSOD defense system; and (5) of the anti-apoptotic protein Bcl2 in Purkinje cells itself. Moreover, the results emphasize the limited comparability of animal CA/R studies because of the heterogeneity of the used experimental regimes. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
26. Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.
- Author
-
Pereira, José Monteiro Sad, Barreira, André Luis, Gomes, Conrado Rodrigues, Ornellas, Felipe Mateus, Ornellas, Débora Santos, Miranda, Luiz Carlos, Cardoso, Lucio Ronaldo, Coutinho-Silva, Robson, Schanaider, Alberto, Morales, Marcelo M., Leite, Maurilo, Takiya, Christina Maeda, and Leite, Maurilo Jr
- Subjects
URETERIC obstruction ,CELL proliferation ,PURINERGIC receptors ,EPITHELIAL cells ,APOPTOSIS ,RNA metabolism ,PROTEIN metabolism ,MUSCLE protein metabolism ,COLLAGEN ,BIOCHEMISTRY ,RESEARCH ,KIDNEYS ,FIBROBLASTS ,NEPHRITIS ,ANIMAL experimentation ,GROWTH factors ,TIME ,RESEARCH methodology ,NEUROTRANSMITTERS ,CELL physiology ,KIDNEY tubules ,INTERLEUKIN-1 ,MACROPHAGES ,FIBROSIS ,MEDICAL cooperation ,EVALUATION research ,AMINES ,RATS ,PHENOMENOLOGY ,CELL motility ,COMPARATIVE studies ,DRUGS ,ANTIGENS ,PHARMACODYNAMICS ,DISEASE complications - Abstract
Background: Previous study showed that purinergic P2X7 receptors (P2X7R) reach the highest expression in the first week after unilateral ureteral obstruction (UUO) in mice, and are involved in the process of inflammation, apoptosis and fibrosis of renal tissue. We, herein, document the role of purinergic P2X7 receptors activation on the third day of UUO, as assessed by means of BBG as its selective inhibitor.Methods: We investigated the effects of brilliant blue G (BBG), a P2X7R antagonist, in the third day of kidney tissue response to UUO in rats. For this purpose, male Wistar rats submitted to UUO or sham operated, received BBG or vehicle (V), comprising four groups: UUO-BBG, UUO-V, sham-BBG and sham-V. The kidneys were harvested on day 3 UUO and prepared for histology, immunohistochemistry (P2X7R, PCNA, CD-68, α-sma, TGF-β1, Heat-shock protein-47, TUNEL assay), quantitative real-time PCR (IL-1β, procollagens type I, III, and IV) for mRNA quantification.Results: The group UUO-V presented an enhancement in tubular cell P2X7-R expression, increase influx of macrophages and myofibroblasts, HSP-47 and TGF- β1 expression. Also, upregulation of procollagen types I, III, and IV, and IL-1β mRNAs were seen. On the other hand, group UUO-BBG showed lower expression of procollagens and IL-1β mRNAs, as well as less immunoreactivity of HSP-47, TGF-β, macrophages, myofibroblasts, and tubular apoptosis. This group also presented increased epithelial cell proliferation.Conclusion: BBG, a known highly selective inhibitor of P2X7R, attenuated renal inflammation, collagen synthesis, renal cell apoptosis, and enhanced renal cell proliferation in the early phase of rat model of UUO. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
27. Detecting Schistosoma mansoni infections among pre-school-aged children in southern Ghana: a diagnostic comparison of urine-CCA, real-time PCR and Kato-Katz assays.
- Author
-
Armoo, Samuel, Cunningham, Lucas J., Campbell, Suzy J., Aboagye, Frank T., Boampong, Freda K., Hamidu, Buhari A., Osei-Atweneboana, Mike Y., Stothard, J. Russell, and Adams, Emily R.
- Subjects
SCHISTOSOMA mansoni ,RAPID tooling ,SCHISTOSOMIASIS ,INFECTION ,ANTIGEN analysis ,SCHISTOSOMIASIS diagnosis ,RESEARCH ,MEDICAL databases ,INFORMATION storage & retrieval systems ,TREMATODA ,ANIMAL experimentation ,BODY fluids ,RESEARCH methodology ,ISOQUINOLINE ,EVALUATION research ,MEDICAL cooperation ,FECES ,COMPARATIVE studies ,CLINICAL medicine ,DISEASE prevalence ,RESEARCH funding ,ROUTINE diagnostic tests ,POLYMERASE chain reaction ,URINALYSIS ,BIOLOGICAL assay ,ANTIGENS - Abstract
Background: In Ghana, pre-school-aged children (PSAC) are at risk of intestinal schistosomiasis and are living in need of praziquantel treatment. To better assess the infection burden within this vulnerable demographic group, we have provided a comparative assessment of the prevalence of Schistosoma mansoni in pre-school-aged children by urine circulating cathodic antigen (CCA) dipsticks, real-time PCR Taqman® faecal assays and Kato-Katz coproscopy.Methods: In all, 190 pre-school-aged children were sampled from three endemic communities (viz. Tomefa, Torgahkope/Adakope, and Manheam) around Weija dam, Southern Ghana. Fresh stool and urine samples were collected from all participants for diagnosis.Results: Among all the three communities, the urine-CCA assay recorded the highest prevalence values of 90.5% (95% CI 80.4-96.4), 87.9% (95% CI 76.7-95), and 81.2% (95% CI 69.9-89.6) in Tomefa, Torgahkope/Adakope, and Manheam respectively. Prevalence by real-time PCR was 50% (95% CI 35.5-64.5), 8% (95% CI 2.2-19.2) and 16.7% (95% CI 8.3-28.5), while by Kato-Katz was 55.6% (95% CI 42.5-68.1), 8.6% (95% CI 2.9-19) and 11.6% (95% CI 5.1-21.6) respectively. Children aged 1 year and over were found to be positive with the urine-CCA assay; by the ages of 3-4, over 50% were urine-CCA patent. The sensitivity and specificity of the POC-CCA dipsticks, when compared against the combined results of Kato-Katz/TaqMan results was found to be 84.1% (95% CI = 72.7-92.1) and 12.9% (95% CI = 6.6-22) respectively.Conclusions: We propose that the urine-CCA dipstick may be a useful rapid diagnostic tool to estimate the prevalence of intestinal schistosomiasis in PSAC, particularly in rapid identification of at-risk areas. However, our assessment has shown that it possible to record false positives when compared to combined Kato-Katz and qPCR results. To guide PSAC praziquantel treatment needs, we propose the urine CCA assay should be included in routine surveillance of intestinal schistosomiasis alongside other diagnostics such as Kato-Katz and urine filtration. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
28. Epimedium Polysaccharide Ameliorates Benzene-Induced Aplastic Anemia in Mice.
- Author
-
He, Jin, Han, Ru, Yu, Gongchang, Lavin, Martin F., Jia, Qiang, Cui, Ping, and Peng, Cheng
- Subjects
ERYTHROCYTES ,SUBCUTANEOUS injections ,REACTIVE oxygen species ,ANIMAL experimentation ,ANTIGENS ,APLASTIC anemia ,APOPTOSIS ,BONE marrow ,DOSE-effect relationship in pharmacology ,HEMOGLOBINS ,HERBAL medicine ,IMMUNITY ,LEUCOCYTES ,CHINESE medicine ,MICE ,ONCOGENES ,ORAL drug administration ,POLYSACCHARIDES ,STEM cells ,T cells ,OXIDATIVE stress ,BENZENE derivatives ,CASPASES ,PLATELET count ,DRUG administration ,DRUG dosage - Abstract
Benzene (BZ) is an important occupational and environmental pollutant. Exposure to BZ may cause aplastic anemia which is characterized as bone marrow hematopoietic failure. In order to reduce the harmful effects of this pollutant, it is necessary to identify additional preventative measures. In this study, we investigated the protective effects of epimedium polysaccharide (EPS), a natural compound with antioxidant and immune-enhancing potency, on aplastic anemia induced by benzene exposure in mice. Male CD-1 mice were randomly divided into five groups including control, BZ (880 mg/kg), LE (EPS low-dose, 20 mg/kg + BZ), ME (EPS middle-dose, 100 mg/kg + BZ), and HE (EPS high-dose, 200 mg/kg + BZ) groups. Animals were exposed to BZ by subcutaneous injection in the presence or absence of EPS via oral administration. All mice were treated 3 times a week for 8 consecutive weeks to develop a mouse model of benzene-induced aplastic anemia (BIAA). Results showed that BZ induced a significant decrease in both white and red blood cells, platelet counts, and hemoglobin level compared with that in the control group (p < 0.01). Treatment of EPS led to a protective effect against these changes particularly in the highest-dose group (HE, p < 0.01). EPS also recovered the decreased number of nucleated cells in peripheral blood cell smears and femur biopsies by BZ exposure. The increased level of reactive oxygen species (ROS) in bone marrow mononuclear cells (BMMNCs) in mice from the BZ group was significantly lower (p < 0.01) in the mice from the highest concentration of EPS (HE) group when compared with that from the control group. In addition, BZ exposure led to a significant increase in the apoptosis rate in BMMNCs which was prevented by EPS in a dose-dependent manner (p < 0.01). The antiapoptosis effect of EPS was through reversing apoptotic proteins such as BAX, Caspase-9 and Caspase-3, and Bcl-2. Finally, EPS treatment partially restored the levels of T cells and the different subtypes except CD80
+ and CD86+ compared with the BZ group (HE, p < 0.05). These results suggest that EPS has protective effects against BIAA via antioxidative stress, immune modulation, and antiapoptosis mechanisms. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
29. The Traditional Chinese Medicine Fufang Shatai Heji (STHJ) Enhances Immune Function in Cyclophosphamide-Treated Mice.
- Author
-
Fan, Kai-Jian, Li, Yun-Wu, Wu, Jing, Li, Jun, Zhang, Jun, Wang, Qi-Shan, Xu, Bing-Xin, Cai, Qing, and Wang, Ting-Yu
- Subjects
ANIMAL experimentation ,ANTIGENS ,B cells ,CYTOKINES ,ENZYME-linked immunosorbent assay ,FLOW cytometry ,GENE expression ,HERBAL medicine ,INFLAMMATORY mediators ,INTERLEUKINS ,KILLER cells ,LYMPHOCYTES ,CHINESE medicine ,MICE ,MOLECULAR structure ,SPLEEN ,THYMUS ,TUMOR necrosis factors ,CYCLOPHOSPHAMIDE ,DRUG administration ,DRUG dosage ,PHARMACODYNAMICS - Abstract
Fufang Shatai Heji (STHJ) is a mixture of traditional Chinese medicines, such as Radix Adenophorae, Radix Pseudostellariae, and Radix Astragali. STHJ is commonly used to treat diseases caused by low immune function, for example, Sjögren's syndrome (SS). The primary objective of this study was to assess the immunopotentiating effect of STHJ using an immunosuppressive mouse model receiving cyclophosphamide (CTX). Following CTX treatment, STHJ was administered by oral gavage for 30 consecutive days. The percentage of specific lymphocyte subpopulations in the spleen was measured by flow cytometry. Levels of inflammatory factors in serum were detected by enzyme-linked immunosorbent assays (ELISAs). The administration of STHJ significantly elevated thymus and spleen indices, increased B cell and natural killer (NK) cell activities, and decreased CD8
+ T, CD8+ CD122+ T, NKT, and γδT cell activities in the CTX-treated mice. In addition, STHJ upregulated the expression of interleukin- (IL-) 2, IL-6, and tumor necrosis factor-α (TNF-α) and downregulated IL-10 expression in CTX-treated mice. In conclusion, STHJ effectively remitted CTX-induced immunosuppression by modulating the balance of lymphocyte subsets and cytokines. Our results suggest STHJ treatment could be used as an effective therapeutic approach to improve immune function in patients with low immunity. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
30. A bivalent antihypertensive vaccine targeting L-type calcium channels and angiotensin AT1 receptors.
- Author
-
Wu, Hailang, Wang, Yiyi, Wang, Gongxin, Qiu, Zhihua, Hu, Xiajun, Zhang, Hongrong, Yan, Xiaole, Ke, Fan, Zou, Anruo, Wang, Min, Liao, Yuhua, and Chen, Xiao
- Subjects
CALCIUM channels ,ANGIOTENSIN receptors ,ANGIOTENSIN II ,HEPATITIS associated antigen ,CARRIER proteins ,ANGIOTENSIN converting enzyme ,VACCINES ,CALCIUM metabolism ,BLOOD pressure ,HYPERTENSION ,BIOLOGICAL models ,RESEARCH ,VIRAL vaccines ,IMMUNIZATION ,ANIMAL experimentation ,RESEARCH methodology ,CELL receptors ,MEDICAL cooperation ,EVALUATION research ,COMBINED vaccines ,RATS ,COMPARATIVE studies ,CALCIUM ,ANTIGENS ,MICE ,PHARMACODYNAMICS - Abstract
Background and Purpose: Hypertension has been the leading preventable cause of premature death worldwide. The aim of this study was to design a more efficient vaccine against novel targets for the treatment of hypertension.Experimental Approach: The epitope CE12, derived from the human L-type calcium channel (CaV 1.2), was designed and conjugated with Qβ bacteriophage virus-like particles to test the efficacy in hypertensive animals. Further, the hepatitis B core antigen (HBcAg)-CE12-CQ10 vaccine, a bivalent vaccine based on HBcAg virus-like particles and targeting both human angiotensin AT1 receptors and CaV 1.2 channels, was developed and evaluated in hypertensive rodents.Key Results: The Qβ-CE12 vaccine effectively decreased the BP in hypertensive rodents. A monoclonal antibody against CE12 specifically bound to L-type calcium channels and inhibited channel activity. Injection with monoclonal antibody against CE12 effectively reduced the BP in angiotensin II-induced hypertensive mice. The HBcAg-CE12-CQ10 vaccine showed antihypertensive effects in hypertensive mice and relatively superior antihypertensive effects in spontaneously hypertensive rats and ameliorated L-NAME-induced renal injury. In addition, no obvious immune-mediated damage or electrophysiological adverse effects were detected.Conclusion and Implications: Immunotherapy against both AT1 receptors and CaV 1.2 channels decreased the BP in hypertensive rodents effectively and provided protection against hypertensive target organ damage without obvious feedback activation of renin-angiotensin system or induction of dominant antibodies against the carrier protein. Thus, the HBcAg-CE12-CQ10 vaccine may provide a novel and promising therapeutic approach for hypertension. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
31. Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.
- Author
-
Miller, Lisa A., Cossette, Chantal, Chourey, Shishir, Ye, Qiuji, Reddy, Chintam Nagendra, Rokach, Joshua, and Powell, William S.
- Subjects
ASCARIS suum ,EOSINOPHILIA ,HOUSE dust mites ,RHESUS monkeys ,KRA ,PRIMATES ,IMMUNOGLOBULIN E ,EOSINOPHILS ,BIOLOGICAL models ,PROTEINS ,PILOT projects ,RESEARCH ,CELL culture ,MITES ,SKIN ,ANIMAL experimentation ,RESEARCH methodology ,ANTIHISTAMINES ,CELL receptors ,CELL physiology ,SKIN inflammation ,MEDICAL cooperation ,EVALUATION research ,CELLULAR signal transduction ,ASCARIS ,COMPARATIVE studies ,RESEARCH funding ,ARACHIDONIC acid ,ALLERGENS ,ANTIGENS ,PHARMACODYNAMICS - Abstract
Background and Purpose: 5-Oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE), acting via the OXE receptor, is unique among 5-lipoxygenase products in its ability to directly induce human eosinophil migration, suggesting its involvement in eosinophilic diseases. To address this hypothesis, we synthesized selective indole-based OXE receptor antagonists. Because rodents lack an OXE receptor orthologue, we sought to determine whether these antagonists could attenuate allergen-induced skin eosinophilia in sensitized monkeys.Experimental Approach: In a pilot study, cynomolgus monkeys with environmentally acquired sensitivity to Ascaris suum were treated orally with the "first-generation" OXE antagonist 230 prior to intradermal injection of 5-oxo-ETE or Ascaris extract. Eosinophils were evaluated in punch biopsy samples taken 6 or 24 hr later. We subsequently treated captive-bred rhesus monkeys sensitized to house dust mite (HDM) allergen with a more recently developed OXE antagonist, S-Y048, and evaluated its effects on dermal eosinophilia induced by either 5-oxo-ETE or HDM.Key Results: In a pilot experiment, both 5-oxo-ETE and Ascaris extract induced dermal eosinophilia in cynomolgus monkeys, which appeared to be reduced by 230. Subsequently, we found that the related OXE antagonist S-Y048 is a highly potent inhibitor of 5-oxo-ETE-induced activation of rhesus monkey eosinophils in vitro and has a half-life in plasma of about 6 hr after oral administration. S-Y048 significantly inhibited eosinophil infiltration into the skin in response to both intradermally administered 5-oxo-ETE and HDM.Conclusions and Implications: 5-Oxo-ETE may play an important role in allergen-induced eosinophilia. Blocking its effects with S-Y048 may provide a novel therapeutic approach for eosinophilic diseases. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
32. Huoxue Wentong Formula ameliorates myocardial infarction in rats through inhibiting CaMKII oxidation and phosphorylation.
- Author
-
Liu, Tiantian, Wang, Qingqing, and Yao, Kuiwu
- Subjects
ANIMAL experimentation ,ANTIGENS ,APOPTOSIS ,BENZOPYRANS ,CARDIOVASCULAR system ,CORONARY arteries ,DIURETICS ,ECHOCARDIOGRAPHY ,ELECTROCARDIOGRAPHY ,GENE expression ,HEART cells ,HEART function tests ,HERBAL medicine ,IMMUNOHISTOCHEMISTRY ,INFLAMMATORY mediators ,CHINESE medicine ,MYOCARDIAL infarction ,MYOCARDIUM ,OXIDATION-reduction reaction ,PHOSPHORYLATION ,PHOSPHOTRANSFERASES ,RATS ,STAINS & staining (Microscopy) ,FLUORESCENT dyes ,PATHOLOGIC neovascularization ,DRUG administration ,DRUG dosage ,PHARMACODYNAMICS - Abstract
Background: The Chinese medicine Huoxue Wentong Formula (HXWTF) was used to treat thoracic obstruction and angina pectoris in clinic, which has not been investigated in myocardial ischemia-induced apoptosis and angiogenic function. Here we aimed to investigate the roles of HXWTF in rats with myocardial ischemia-induced apoptosis and angiogenesis disorders, as well as to reveal the potential mechanisms. Methods: Male SD rats were subjected to coronary artery ligation followed by HXWTF (420, 840 and 1680 mg/kg/day, p.o.) or isosorbide mononitrate (6.3 mg/kg/day, p.o.) treatment for 4 weeks. Electrocardiogram (ECG) and Echocardiography (ECHO) were used to measure cardiac function. Hematoxylin and eosin (H&E) staining and CD34/α-SMA immunohistochemical staining were performed to observe the ischemic heart sections pathological changes and angiogenesis. Then, the effects on cardiomyocyte apoptosis of H9c2 and tube formation of HCMECs were observed, as well as the changes in the levels of total calmodulin dependent protein kinase II (t-CaMKII), phosphorylated CaMKII (p-CaMKII), oxidized CaMKII (ox-CaMKII), CD34, and Bcl-2/Bax ratio were detected. Results: Rats with coronary artery ligation exhibited abnormal cardiac function, enlarged myocardial space, disorderly arranged myocardial fibers, inflammatory cells infiltrated, and aggravated myocardial cell apoptosis, along with angiogenesis dysfunction. The expressions of CD34, p-CaMKII, and ox-CaMKII were elevated and Bcl-2/Bax ratio was diminished in ischemic hearts and H/SD-treated H9c2 or HCMECs, while HXWTF treatment completely rescued angiogenic dysfunction, inhibited cardiomyocyte apoptosis, and down-regulated cardiac CaMKII oxidation and phosphorylation activities. Conclusion: Our study demonstrates that HXWTF improves myocardial infarction possibly through inhibiting CaMKII oxidation and phosphorylation levels, facilitating angiogenic function and alleviating cardiomyocyte apoptosis. Thus, therapeutics targeting CaMKII activities may be a promising strategy for rescuing ischemic cardiomyopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
33. CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis.
- Author
-
Guanhua Song, Tingting Feng, Ru Zhao, Qiqi Lu, Yutao Diao, Qingwei Guo, Zhaoxia Wang, Yuang Zhang, Luna Ge, Jihong Pan, Lin Wang, Jinxiang Han, Song, Guanhua, Feng, Tingting, Zhao, Ru, Lu, Qiqi, Diao, Yutao, Guo, Qingwei, Wang, Zhaoxia, and Zhang, Yuang
- Subjects
PROTEINS ,BIOLOGICAL models ,RESEARCH ,SYNOVIAL membranes ,FIBROBLASTS ,CELL culture ,WESTERN immunoblotting ,ANIMAL experimentation ,RESEARCH methodology ,CELL physiology ,EVALUATION research ,MEDICAL cooperation ,CELL motility ,CELLULAR signal transduction ,COMPARATIVE studies ,RHEUMATOID arthritis ,GLYCOPROTEINS ,ANTIGENS ,MICE - Abstract
Objective: The aim of this study was to investigate the role of CD109 in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLSs) and to evaluate its potential as a therapeutic target.Methods: CD109 expression was examined in synovial tissues and FLSs from RA patients and collagen-induced arthritis (CIA) model mice. CD109-deficient mice were developed to evaluate the severity of CIA. Small interfering RNAs and a neutralising antibody against CD109 (anti-CD109) were designed for functional or treatment studies in RA FLSs and CIA.Results: CD109 was found to be abundantly expressed in the synovial tissues from RA patients and CIA mice. CD109 expression in RA FLSs was upregulated by inflammatory stimuli, such as interleukin-1β and tumour necrosis factor-α. Silencing of CD109 or anti-CD109 treatment reduced proinflammatory factor production, cell migration, invasion, chemoattractive potential and osteoclast differentiation, thereby reducing the deleterious inflammatory response of RA FLSs in vitro. Mice lacking CD109 were protected against arthritis in the CIA model. Anti-CD109 treatment prevented the onset and ameliorated the severity of CIA lesions.Conclusion: Our study uncovers an antiarthritic role for CD109 and suggests that CD109 inhibition might serve as a promising novel therapeutic strategy for RA. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
34. CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.
- Author
-
Kråkenes, Torbjørn, Herdlevær, Ida, Raspotnig, Margrethe, Haugen, Mette, Schubert, Manja, Vedeler, Christian A., and Herdlevaer, Ida
- Subjects
CEREBELLUM degeneration ,RECOMBINANT proteins ,CEREBROSPINAL fluid ,IMMUNOGLOBULINS ,CANCER cells ,AUTOANTIBODIES ,RESEARCH ,PARANEOPLASTIC syndromes ,NERVE tissue proteins ,ANIMAL experimentation ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,CEREBELLUM ,RATS ,COMPARATIVE studies ,EPITHELIAL cells ,ANTIGENS - Abstract
The pathogenesis of Yo-mediated paraneoplastic cerebellar degeneration (PCD) is unclear. We applied cerebrospinal fluid and serum from PCD patients as well as CDR2 and CDR2L antibodies to neuronal tissue, cancer cell lines, and cells transfected with recombinant CDR2 and CDR2L to elucidate which is the major antigen of Yo antibodies. We found that Yo antibodies bound endogenous CDR2L, but not endogenous CDR2. However, Yo antibodies can bind the recombinant CDR2 protein used in routine clinical testing for these antibodies. Because Yo antibodies only bind endogenous CDR2L, we conclude that CDR2L is the major antigen of Yo antibodies in PCD. ANN NEUROL 2019;86:316-321. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
35. Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.
- Author
-
Czesnikiewicz‐Guzik, Marta, Nosalski, Ryszard, Mikolajczyk, Tomasz P, Vidler, Francesca, Dohnal, Tomasz, Dembowska, Elzbieta, Graham, Delyth, Harrison, David G, Guzik, Tomasz J, and Czesnikiewicz-Guzik, Marta
- Subjects
HYPERTENSION ,PORPHYROMONAS gingivalis ,ANGIOTENSIN II ,IMMUNE response ,BACTERIAL antigens ,ANTIGENS ,HEART ventricle diseases ,ANIMAL experimentation ,COMPARATIVE studies ,DOSE-effect relationship in pharmacology ,FLOW cytometry ,INFLAMMATION ,RESEARCH methodology ,MEDICAL cooperation ,MICE ,RESEARCH ,T cells ,EVALUATION research ,GRAM-negative anaerobic bacteria - Abstract
Background and Purpose: Emerging evidence indicates that hypertension is mediated by immune mechanisms. We hypothesized that exposure to Porphyromonas gingivalis antigens, commonly encountered in periodontal disease, can enhance immune activation in hypertension and exacerbate the elevation in BP, vascular inflammation and vascular dysfunction.Experimental Approach: Th1 immune responses were elicited through immunizations using P. gingivalis lysate antigens (10 μg) conjugated with aluminium oxide (50 μg) and IL-12 (1 μg). The hypertension and vascular endothelial dysfunction evoked by subpressor doses of angiotensin II (0.25 mg·kg-1 ·day-1 ) were studied, and vascular inflammation was quantified by flow cytometry and real-time PCR.Key Results: Systemic T-cell activation, a characteristic of hypertension, was exacerbated by P. gingivalis antigen stimulation. This translated into increased aortic vascular inflammation with enhanced leukocyte, in particular, T-cell and macrophage infiltration. The expression of the Th1 cytokines, IFN-γ and TNF-α, and the transcription factor, TBX21, was increased in aortas of P. gingivalis/IL-12/aluminium oxide-immunized mice, while IL-4 and TGF-β were unchanged. These immune changes in mice with induced T-helper-type 1 immune responses were associated with an enhanced elevation of BP and endothelial dysfunction compared with control mice in response to 2 week infusion of a subpressor dose of angiotensin II.Conclusions and Implications: These results support the concept that Th1 immune responses induced by bacterial antigens such as P. gingivalis can increase sensitivity to subpressor pro-hypertensive insults such as low-dose angiotensin II, thus providing a mechanistic link between chronic infection, such as periodontitis, and hypertension.Linked Articles: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
36. Black Rice (Oryza sativa L.) Fermented with Lactobacillus casei Attenuates Osteoclastogenesis and Ovariectomy-Induced Osteoporosis.
- Author
-
Lee, Young Min, Kim, In Sook, and Lim, Beong Ou
- Subjects
ACID phosphatase ,REACTIVE oxygen species ,ANIMAL experimentation ,ANTIGENS ,BIOMARKERS ,BONE resorption ,BONE growth ,CELL differentiation ,CELL receptors ,FERMENTATION ,GENE expression ,LACTOBACILLUS ,MACROPHAGES ,ONCOGENES ,ORAL drug administration ,OSTEOPOROSIS ,OVARIECTOMY ,PROTEIN kinases ,PROTEOLYTIC enzymes ,RATS ,RICE ,T cells ,TUMOR necrosis factors ,DNA-binding proteins - Abstract
The aim of the present study was to investigate the antiosteoclastogenic effects of black rice (Oryza sativa L.) fermented with Lactobacillus casei (LAB) in RANKL-induced RAW macrophage cells and its antiosteoporosis activity against ovariectomy-induced osteoporosis in rats. LAB extract (LABE) treatment attenuated receptor activator of nuclear factor-kappa B (NF-κB) ligand-induced osteoclastic differentiation in RAW cells by inhibiting intercellular reactive oxygen species generation and downregulating the activation of mitogen-activated protein kinases and NF-κB, leading to the downregulation of c-Fos and expression of nuclear factor of activated T cells c1. This consequently suppressed the expression of osteoclast-specific genes including those for cathepsin K, tartrate-resistant acid phosphatase, calcitonin receptor, and integrin β3. Oral administration of LABE protected against ovariectomy-induced bone loss by significantly inhibiting bone architecture alterations and improving serum bone turnover markers in ovariectomized rats. The findings suggest that the antiosteoporotic activity of LABE may be derived from its antiosteoclastic and anti-bone-resorptive activities. LABE has potential as a promising functional material or substrate to prepare protective agents for osteoporosis and osteoclast-mediated bone diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
37. Combination of Ligusticum Chuanxiong and Radix Paeonia Promotes Angiogenesis in Ischemic Myocardium through Notch Signalling and Mobilization of Stem Cells.
- Author
-
Shi, Wei-Li, Zhao, Jun, Yuan, Rong, Lu, Yan, Xin, Qi-Qi, Liu, Yu, Cong, Wei-Hong, and Chen, Ke-Ji
- Subjects
PHYTOTHERAPY ,ACE inhibitors ,ANIMAL experimentation ,ANTIGENS ,CELL receptors ,CELL motility ,CELLULAR signal transduction ,CHEMOKINES ,COMBINATION drug therapy ,CORONARY arteries ,FLUORESCENT antibody technique ,GENE expression ,LIGATURE (Surgery) ,MEDICINAL plants ,MICE ,MYOCARDIAL infarction ,MYOCARDIUM ,NEOVASCULARIZATION ,PROTEOLYTIC enzymes ,STAINS & staining (Microscopy) ,STEM cells ,TRANSCRIPTION factors ,WESTERN immunoblotting ,VENTRICULAR ejection fraction ,CHEMICAL inhibitors ,PREVENTION - Abstract
Objective. To study the cardioprotective mechanism by which the combination of Chuanxiong (CX) and Chishao (CS) promotes angiogenesis. Methods. Myocardial infarction (MI) mouse models were induced by ligation of the left anterior descending coronary artery. The effects on cardiac function were evaluated in the perindopril tert-butylamine group (PB group) (3 mg/kg/d), CX group (55 mg/kg/d), CS group (55 mg/kg/d), and CX and CS combination (CX-CS) group (27.5 mg/kg/d CX plus 27.5 mg/kg/d CS). RO4929097, an inhibitor of Notch γ secretase, was used (10 mg/kg/d) to explore the role of Notch signalling in the CX-CS-induced promotion of angiogenesis in the myocardial infarcted border zone (IBZ). The left ventricular ejection fraction (LVEF) and percentage of MI area were evaluated with animal ultrasound and Masson staining. The average optical densities (AODs) of CD31 and vWF in the myocardial IBZ were detected by immunofluorescence. Angiogenesis-related proteins including hypoxia-inducible factor 1-alpha (HIF-1α), fibroblast growth factor receptor 1 (FGFR-1), Notch1 and Notch intracellular domain (NICD), and stem cell mobilization-related proteins including stromal cell-derived factor 1 (SDF-1), C-X-C chemokine receptor type 4 (CXCR-4), and cardiotrophin1 were detected by western blot analysis. Results. Compared with the model group, the CX-CS and PB groups both showed markedly improved LVEF and decreased percentage of MI area after 21 days of treatment. Although the CX group and CS group showed increased LVEF and decreased MI areas compared with the model group, the difference was not significant. The AOD of CD31 in the IBZ in both the model and the CX-CS-I group was markedly reduced compared with that in the sham group. CX-CS significantly increased the CD31 AOD in the IBZ and decreased the AODs of CD31 and vWF in the infarct zone compared with those in the model group. The expression of HIF-1α in both the model group and the CX-CS group was higher than that in the sham group. Compared with the model group, the expression of FGFR-1, SDF-1, cardiotrophin1, Notch1, and NICD was increased in the CX-CS group. Notch1 and NICD expression in the CX-CS-I group was reduced compared with that in the CX-CS group. Conclusions. The combination of CX and CS protected cardiomyocytes in the IBZ better than CX or CS alone. The mechanism by which CX-CS protects ischemic myocardium may be related to the proangiogenesis effect of CX-CS exerted through Notch signalling and the mobilization of stem cells to the IBZ. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. Muscle Atrophy Marker Expression Differs between Rotary Cell Culture System and Animal Studies.
- Author
-
Harding, Charles P. and Vargis, Elizabeth
- Subjects
ANIMAL experimentation ,ANTIGENS ,BIOMARKERS ,CELL culture ,CELL differentiation ,CELL lines ,CELL physiology ,GENE expression ,LATEX ,MESSENGER RNA ,MICE ,MUSCLE proteins ,MUSCULAR atrophy ,PLASTICS ,PROTEIN kinases ,CASPASES ,IN vitro studies ,IN vivo studies ,PREVENTION - Abstract
Muscular atrophy, defined as the loss of muscle tissue, is a serious issue for immobilized patients on Earth and for humans during spaceflight, where microgravity prevents normal muscle loading. In vitro modeling is an important step in understanding atrophy mechanisms and testing countermeasures before animal trials. The most ideal environment for modeling must be empirically determined to best mimic known responses in vivo. To simulate microgravity conditions, murine C2C12 myoblasts were cultured in a rotary cell culture system (RCCS). Alginate encapsulation was compared against polystyrene microcarrier beads as a substrate for culturing these adherent muscle cells. Changes after culture under simulated microgravity were characterized by assessing mRNA expression of MuRF1, MAFbx, Caspase 3, Akt2, mTOR, Ankrd1, and Foxo3. Protein concentration of myosin heavy chain 4 (Myh4) was used as a differentiation marker. Cell morphology and substrate structure were evaluated with brightfield and fluorescent imaging. Differentiated C2C12 cells encapsulated in alginate had a significant increase in MuRF1 only following simulated microgravity culture and were morphologically dissimilar to normal cultured muscle tissue. On the other hand, C2C12 cells cultured on polystyrene microcarriers had significantly increased expression of MuRF1, Caspase 3, and Foxo3 and easily identifiable multinucleated myotubes. The extent of differentiation was higher in simulated microgravity and protein synthesis more active with increased Myh4, Akt2, and mTOR. The in vitro microcarrier model described herein significantly increases expression of several of the same atrophy markers as in vivo models. However, unlike animal models, MAFbx and Ankrd1 were not significantly increased and the fold change in MuRF1 and Foxo3 was lower than expected. Using a standard commercially available RCCS, the substrates and culture methods described only partially model changes in mRNAs associated with atrophy in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
39. Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses.
- Author
-
Bo Chen, Vousden, Katherine A., Naiman, Brian, Turman, Sean, Hong Sun, Shu Wang, Vinall, Lisa M. K., Kemp, Benjamin P., Kasturiangan, Srinath, Rees, D. Gareth, Grant, Ethan, Hinrichs, Mary Jane, Eck, Steven, DiGiandomenico, Antonio, Borrok, M. Jack, Neang Ly, Ximing Xiong, Gonzalez, Carlos, Morehouse, Christopher, and Yue Wang
- Subjects
REACTIVE oxygen species ,ANIMAL experimentation ,ANTIGENS ,AUTOANTIBODIES ,AUTOIMMUNE diseases ,CELL receptors ,COMPARATIVE studies ,DENDRITIC cells ,IMMUNOGLOBULINS ,IMMUNOLOGICAL adjuvants ,INTERLEUKINS ,RESEARCH methodology ,MEDICAL cooperation ,MICE ,NEUTROPHILS ,PRIMATES ,RESEARCH ,TUMOR necrosis factors ,EVALUATION research ,PHARMACODYNAMICS - Abstract
Objective: Immune complexes (ICs) play a critical role in the pathology of autoimmune diseases. The aim of this study was to generate and characterise a first-in-class anti-FcγRIIA antibody (Ab) VIB9600 (previously known as MEDI9600) that blocks IgG immune complex-mediated cellular activation for clinical development.Methods: VIB9600 was humanised and optimised from the IV.3 Ab. Binding affinity and specificity were determined by Biacore and ELISA. Confocal microscopy, Flow Cytometry-based assays and binding competition assays were used to assess the mode of action of the antibody. In vitro cell-based assays were used to demonstrate suppression of IC-mediated inflammatory responses. In vivo target suppression and efficacy was demonstrated in FcγRIIA-transgenic mice. Single-dose pharmacokinetic (PK)/pharmacodynamic study multiple dose Good Laboratory Practice (GLP) toxicity studies were conducted in non-human primates.Results: We generated a humanised effector-deficient anti-FcγRIIA antibody (VIB9600) that potently blocks autoantibody and IC-mediated proinflammatory responses. VIB9600 suppresses FcγRIIA activation by blocking ligand engagement and by internalising FcγRIIA from the cell surface. VIB9600 inhibits IC-induced type I interferons from plasmacytoid dendritic cells (involved in SLE), antineutrophil cytoplasmic antibody (ANCA)-induced production of reactive oxygen species by neutrophils (involved in ANCA-associated vasculitis) and IC-induced tumour necrosis factor α and interleukin-6 production (involved in rheumatoid arthritis). In FcγRIIA transgenic mice, VIB9600 suppressed antiplatelet antibody-induced thrombocytopaenia, acute anti-GBM Ab-induced nephritis and anticollagen Ab-induced arthritis. VIB9600 also exhibited favourable PK and safety profiles in cynomolgus monkey studies.Conclusions: VIB9600 is a specific humanised antibody antagonist of FcγRIIA with null effector function that warrants further clinical development for the treatment of IC-mediated diseases. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
40. Gingipains disrupt F‐actin and cause osteoblast apoptosis via integrin β1.
- Author
-
Qiu, Q., Zhang, F., Wu, J., Xu, N., and Liang, M.
- Subjects
PORPHYROMONAS gingivalis ,F-actin ,OSTEOBLASTS ,APOPTOSIS ,CELL morphology ,INTEGRINS ,CYSTEINE proteinase inhibitors ,PROTEASE inhibitors ,ANIMAL experimentation ,ANTIGENS ,CALCIUM-binding proteins ,CELL physiology ,FLOW cytometry ,GENE expression ,IODIDES ,MICE ,MUSCLE proteins ,PROTEOLYTIC enzymes ,STAINS & staining (Microscopy) ,TRANSFERASES ,WESTERN immunoblotting ,GRAM-negative anaerobic bacteria - Abstract
Background and Objective: The aim of this study was to explore the cellular mechanisms underlying gingipain‐caused changes in cell morphology and apoptosis of osteoblasts. Material and Methods: Human calvarial osteoblasts and mouse osteoblasts MC3T3‐E1 were treated with gingipain extracts from Porphyromonas gingivalis stain W83. Apoptosis was detected with annexin V and propidium iodide flow cytometry analysis or terminal deoxynucleotidyl transferase mediated dUTP nick‐end labeling staining. F‐actin was determined by immunostaining. Western blotting was used to detect protein expression. Knocking down and overexpressing approaches were used to determine the role of integrin β1. Results: Osteoblasts exposed to gingipain extracts displayed increased apoptosis, accompanied by loss of F‐actin integrity and cell shrinkage. The effects of gingipain extracts were abolished by the cysteine protease inhibitor N‐tosyl‐ l‐lysyl chloromethyl‐ketone. Notably, gingipain extracts resulted in reduction of integrin β1, accompanied by diminished active RhoA whereas without effect on the total RhoA. Knockdown of integrin β1 resembled those seen in gingipain‐treated osteoblasts. By contrast, the effects of gingipain extracts were abrogated by either overexpression of integrin β1 or presence of RhoA agonist CN03. Conclusion: Gingipain‐induced F‐actin disruption and apoptosis are mediated by the degradation of integrin β1 and inhibition of RhoA activity, which account for osteoblast apoptosis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
41. Preclinical Evaluation of In Vitro and In Vivo Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus.
- Author
-
Kim, Hong, Jang, Eungyeong, Kim, So-Young, Choi, Ji-Yoon, Lee, Na-Rae, Kim, Dae-Sung, Lee, Kyung-Tae, Inn, Kyung-Soo, Kim, Bum-Joon, and Lee, Jang-Hoon
- Subjects
ANIMAL experimentation ,ANTIGENS ,ANTIVIRAL agents ,CELL lines ,CYTOKINES ,DNA ,CLINICAL drug trials ,DRUG toxicity ,ENZYME inhibitors ,HEPATITIS ,HEPATITIS viruses ,HERBAL medicine ,INFLAMMATION ,LIVER ,MICE ,RATS ,RNA ,PLANT extracts ,IN vitro studies ,IN vivo studies ,PHARMACODYNAMICS - Abstract
Hepatitis B virus (HBV) infectious diseases currently remain incurable due to limitations of conventional antivirals such as incapability of eradicating HBV DNA, prolonged use, drug resistance, and virological relapse. KCT-01, a 30% ethanol extract consisting of Artemisia capillaris, Sanguisorba officinalis, and Curcuma longa, was newly developed. The objective of this study was to investigate pharmacological activities of KCT-01 against HBV using HepG2.2.15 cells and a hydrodynamic injection model. KCT-01 significantly lowered antigen secretion, virion production, and pgRNA synthesis in HepG2.2.15 cells without affecting cell viability. KCT-01 administration also resulted in significant decrease of serum virion production, liver covalently closed circular (ccc) DNA levels, and mRNA synthesis of cytokines in the liver of mice injected with HBV DNA hydrodynamically. Interestingly, coadministration of KCT-01 with entecavir enhanced its in vitro and in vivo antiviral activities. Moreover, safety of KCT-01 was assured up to 5000 mg/kg in rats in both single and repeated-dose preclinical studies. Taken together, our findings demonstrate that KCT-01 is capable of suppressing HBV replication and inflammatory cytokine production in in vitro and in vivo models without showing toxicity, suggesting the potential of using KCT-01 alone or in combination with entecavir as antiviral agent. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
42. Dietary supplementation with blueberry partially restores T-cell-mediated function in high-fat-diet-induced obese mice.
- Author
-
Lewis, Erin D., Ren, Zhihong, DeFuria, Jason, Obin, Martin S., Meydani, Simin N., and Wu, Dayong
- Subjects
BLUEBERRIES ,CELL proliferation ,ADIPOSE tissues ,ANIMAL experimentation ,ANTIGENS ,CELLULAR immunity ,CYTOKINES ,DIETARY supplements ,FAT content of food ,IMMUNITY ,INTERFERONS ,LEUCOCYTES ,LOW-fat diet ,MICE ,OBESITY ,PLANT proteins ,T cells ,TUMOR necrosis factors ,LIPOPOLYSACCHARIDES - Abstract
Blueberry, rich in antioxidant and anti-inflammatory phytochemicals, has been demonstrated to lower inflammatory status in adipose induced by high-fat diet (HFD) and obesity. The effect of blueberry on systemic immune functions has not been examined. C57BL/6 mice were randomised to one of three diets – low-fat diet (LFD), HFD and HFD plus 4 % (w/w) blueberry (HFD+B) – for 8 or 12 weeks.
Ex vivo T-cell mitogens (concanavalin A (Con A); phytohaemagglutinin), T-cell antibody (anti-CD3; anti-CD3/CD28)-stimulated T-cell proliferation and cytokine production were assessed. After 8 weeks, both HFD groups weighed more (>4 g) than the LFD group; after 12 weeks, HFD+B-fed mice weighed more (>6 g) and had 41 % more adipose tissue than HFD-fed mice (P <0·05). After 12 weeks, T-cell proliferation was less in both HFD groups, compared with the LFD group. HFD-associated decrements in T-cell proliferation were partially (10–50 %) prevented by blueberry supplementation. At 12 weeks, splenocytes from HFD mice, but not from HFD+B mice, produced 51 % less IL-4 (CD3/CD28) and 57 % less interferon-γ (Con A) compared with splenocytes from LFD mice (P <0·05). In response to lipopolysaccharide challenge, splenocytes from both HFD groups produced 24–30 % less IL-6 and 27–33 % less TNF-α compared with splenocytes from LFD mice (P <0·05), indicating impaired acute innate immune response. By demonstrating deleterious impacts of HFD feeding on T-cell proliferation and splenocyte immune responses, our results provide insights into how HFD/obesity can disrupt systemic immune function. The protective effects of blueberry suggest that dietary blueberry can buttress T-cell and systemic immune function against HFD-obesity-associated insults. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
43. CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.
- Author
-
Luo, Liang, Liu, Yangli, Chen, Dubo, Chen, Fengjia, Lan, Hai Bing, and Xie, Canmao
- Subjects
OBSTRUCTIVE lung disease diagnosis ,ANIMAL experimentation ,HYPOXEMIA ,ANTIGENS ,APOPTOSIS ,BIOMARKERS ,CELL lines ,CELL motility ,EXTRACELLULAR space ,GENE expression ,RATS ,DISEASE exacerbation ,DISEASE progression ,EARLY diagnosis ,MATRIX metalloproteinases ,VASCULAR remodeling - Abstract
Chronic obstructive pulmonary disease (COPD) is one of the common and underdiagnosed diseases with the highest morbidity and mortality in the world. The development of COPD can lead to pulmonary vascular remodeling and pulmonary hypertension, further causing the occurrence of pulmonary heart disease. Therefore, attenuation of pulmonary vascular remodeling and pulmonary hypertension caused by COPD can significantly delay cardiovascular complications. In the study, we firstly found that the expression of CD30 and CD30L was increased in COPD. Importantly, the serum CD30L levels were significantly higher in patients with stable COPD relative to those with acute exacerbation of COPD (AECOPD). This suggested that CD30 might be related to the development of COPD. In addition, we found that the expression of CD30 in the COPD rat model was significantly increased compared with control group. And treatment with the anti-CD30 antibody reduced the serum concentration and tissue expression of CD30 in rat. Importantly, anti-CD30 antibody alleviated pulmonary vascular remodeling in COPD model rats. This suggested that CD30 played an important role in the course of COPD. Finally, we found that, in the HPASMC and HPAEC cell lines, CD30 can affect the cell viability and cell migration and inhibited hypoxia-induced cell apoptosis in a concentration-dependent manner. We also found CD30 induced extracellular matrix formation through decreasing the expression of MMP-2, thus promoting the pulmonary vascular remodeling. The study indicated that CD30 and CD30L were involved in pulmonary vascular remodeling and inflammatory response in COPD. Altogether, CD30 might be a marker for the early diagnosis and progression of COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
44. Anterior Cruciate Ligament Transection–Induced Cellular and Extracellular Events in Menisci: Implications for Osteoarthritis.
- Author
-
Xie, Jing, Zhang, Demao, Lin, Yunfeng, Yuan, Quan, and Zhou, Xuedong
- Subjects
ANTERIOR cruciate ligament surgery ,ANIMAL experimentation ,ANTERIOR cruciate ligament ,ANTERIOR cruciate ligament injuries ,ANTIGENS ,BIOLOGICAL models ,CARTILAGE cells ,CHEMOKINES ,COLLAGEN ,ENZYME-linked immunosorbent assay ,EXTRACELLULAR space ,FISHER exact test ,FLUORESCENT antibody technique ,IMMUNOHISTOCHEMISTRY ,INFLAMMATION ,INTERLEUKINS ,MACROPHAGES ,RESEARCH methodology ,MEMBRANE proteins ,MENISCUS (Anatomy) ,MICE ,OSTEOARTHRITIS ,OXIDOREDUCTASES ,POLYMERASE chain reaction ,PROBABILITY theory ,RESEARCH funding ,STAINS & staining (Microscopy) ,STATISTICS ,STEM cells ,T cells ,TISSUE culture ,TUMOR necrosis factors ,WESTERN immunoblotting ,DATA analysis ,DESCRIPTIVE statistics ,METALLOENDOPEPTIDASES ,MATRIX metalloproteinases ,ONE-way analysis of variance - Abstract
Background: The meniscus plays an important role in knee joint diseases such as osteoarthritis (OA). Meniscal injuries can be accompanied by joint catabolic events initiated by inflammation, leading to articular cartilage destruction, but the cellular events responsible for intrinsic meniscal injury and the extracellular matrix changes necessary for meniscal degradation are not well known. Purpose: To explore the cellular and matrix-related changes of menisci based on a mouse OA model of anterior cruciate ligament transection (ACLT). Study Design: Controlled laboratory study. Methods: A mouse ACLT OA model was established by transection of anterior cruciate ligaments on the right knee joints of 8-week-old male (n = 34) and female (n = 34) C57 mice. The knee joints were collected at 1, 2, 4, and 8 weeks after ACLT surgery, and the meniscal changes were analyzed by radiography, histology, immunohistochemistry, immunoblot, and quantitative real-time polymerase chain reaction. Results: The deterioration of menisci was more extensive than that of articular cartilage and subchondral bone at 4 weeks after ACLT surgery. The rapid loss of collagen II and Sox9 in chondrocyte-like cells in the white-white zone of menisci was confirmed, and the activation of potential meniscus progenitor cells and chondroblasts was identified based on the increase of CD90, CD105, and Runx2. Further, the intrinsic inflammation in the bone marrow–like zone of menisci was activated by enhancement of dendritic cells (CD11c
+ ), T cells (CD3+ ), and macrophages (F4/80+ ) with the increase of the inflammatory factors interleukin 1β and tumor necrosis factor α. Finally, the extracellular matrix events involving changes in chemokines, increases of matrix proteases (matrix metalloproteinases and ADAMTS5), and decreases of lysyl oxidase family were elucidated. Conclusion: ACLT-induced meniscal changes not only could explain the contribution of the meniscus to the progress of OA but also could provide a cue for initiation of preventive treatments in the early stages of OA. Clinical Relevance: This study provides support for better protection of menisci in ACL injury–induced conditions such as OA and indicates that menisci should be considered in the development of clinical pharmacological interventions. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
45. Effects of massage on the expression of proangiogenic markers in rat skin.
- Author
-
Ratajczak-Wielgomas, Katarzyna, Kassolik, Krzysztof, Grzegrzolka, Jedrzej, Halski, Tomasz, Piotrowska, Aleksandra, Mieszala, Katarzyna, Wilk, Iwona, Podhorska-Okolow, Marzenna, Dziegiel, Piotr, and Andrzejewski, Waldemar
- Subjects
ANIMAL experimentation ,ANTIGENS ,BIOMARKERS ,GENE expression ,GROWTH factors ,IMMUNOHISTOCHEMISTRY ,MASSAGE therapy ,NEOVASCULARIZATION ,POLYMERASE chain reaction ,RATS ,VASCULAR endothelial growth factors - Abstract
Introduction. Massage is a physiotherapeutic treatment, commonly used in both therapy and restoration of normal body functions. The aim of this work was to determine the effects of skin massage on stimulating the expression of angiogenesis-initiating factors, i.e. VEGF-A, FGF-2 (bFGF) and CD34 and on skin regeneration processes. Material and methods. The study was conducted on 48 Buffalo strain rats, randomly divided into two groups. In the first group (M, the massaged group), massage was applied five times a week for 7 weeks. In the second study group (C, the control group), the massage was omitted. Massage consisted of spiral movements at the plantar surface of skin for 5 min on each rear extremity. The gene expression of proangiogenic factors, including VEGF-A, FGF-2, CD34 at the mRNA level was determined using real-time PCR. Immunohistochemistry was performed on paraffin sections of rat skin to determine VEGF-A, FGF-2 CD34 and Ki-67 expression. Results. An increase in mRNA expression in the skin of the rat's rear extremity for VEGF-A and FGF-2 in the first week of the experiment was shown in the M group compared with the control rats. The upregulation of CD34 mRNA expression was also observed in the M group. We observed positive correlations between VEGF-A mRNA expression and the expression of mRNA for FGF-2 and CD34, as well as correlation between the expression of mRNA for FGF-2 and CD34. The immunohistochemical expression of VEGF-A, FGF-2 and CD34 was at a much lower level in the skin of control rats relative to the skin of massaged animals. Moreover, significantly higher immunoreactivity was shown for nuclear protein Ki-67 in epidermal cells in the M group compared with the C group. Conclusions. Rat skin massage increased the expression of the main angiogenesis-stimulating factors and the proliferative activity of epidermal cells, which can stimulate skin regeneration and tissue repairing processes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
46. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
- Author
-
Lo, Jeannette, Xia, Chang-Qing, Peng, Ruihua, and Clare-Salzler, Michael J.
- Subjects
DIABETES ,DENDRITIC cells ,CELLULAR therapy ,IMMUNOREGULATION ,DISEASE progression ,LABORATORY mice ,IMMUNOLOGY ,PROTEIN metabolism ,IMMUNE system physiology ,TREATMENT of diabetes ,ANIMAL experimentation ,ANIMALS ,ANTIGENS ,BIOLOGICAL models ,CELL culture ,CELL differentiation ,CELL physiology ,CELLULAR immunity ,IMMUNITY ,IMMUNIZATION ,IMMUNOLOGICAL tolerance ,IMMUNOLOGY technique ,TYPE 1 diabetes ,ISLANDS of Langerhans ,MICE ,T cells ,PHYSIOLOGY - Abstract
Dendritic cell (DC) immunotherapy has been effective for prevention of type 1 diabetes (T1D) in NOD mice but fails to protect if initiated after active autoimmunity. As autoreactivity expands inter- and intramolecularly during disease progression, we investigated whether DCs unpulsed or pulsed with β cell antigenic dominant determinants (DD), subdominant determinants (SD), and ignored determinants (ID) could prevent T1D in mice with advanced insulitis. We found that diabetes was significantly delayed by DC therapy. Of interest, DCs pulsed with SD or ID appeared to provide better protection. T lymphocytes from DC-treated mice acquired spontaneous proliferating capability during in vitro culture, which could be largely eliminated by IL-2 neutralizing antibodies. This trend maintained even 29 weeks after discontinuing DC therapy and appeared antigen-independent. Furthermore, CD4+Foxp3+ T regulatory cells (Tregs) from DC-treated mice proliferated more actively in vitro compared to the controls, and Tregs from DC-treated mice showed significantly enhanced immunosuppressive activities in contrast to those from the controls. Our study demonstrates that DC therapy leads to long-lasting immunomodulatory effects in an antigen-dependent and antigen-independent manner and provides evidence for peptide-based intervention during a clinically relevant window to guide DC-based immunotherapy for autoimmune diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
47. Transient Abnormalities in Masking Tuning Curve in Early Progressive Hearing Loss Mouse Model.
- Author
-
Souchal, Marion, Labanca, Ludimila, Alves da Silva Carvalho, Sirley, Macedo de Resende, Luciana, Blavignac, Christelle, Avan, Paul, and Giraudet, Fabrice
- Subjects
ANIMAL experimentation ,ANTIGENS ,AUDITORY perception ,HAIR cells ,HEARING disorders ,MASKING (Psychology) ,MICE ,OTOACOUSTIC emissions ,ACOUSTIC stimulation - Abstract
Damage to cochlear outer hair cells (OHCs) usually affects frequency selectivity in proportion to hearing threshold increase. However, the current clinical heuristics that attributes poor hearing performance despite near-normal auditory sensitivity to auditory neuropathy or “hidden” synaptopathy overlooks possible underlying OHC impairment. Here, we document the part played by OHCs in influencing suprathreshold auditory performance in the presence of noise in a mouse model of progressive hair cell degeneration, the CD1 strain, at postnatal day 18–30 stages when high-frequency auditory thresholds remained near-normal. Nonetheless, total loss of high-frequency distortion product otoacoustic emissions pointed to nonfunctioning basal OHCs. This “discordant profile” came with a huge low-frequency shift of masking tuning curves that plot the level of interfering sound necessary to mask the response to a probe tone, against interfering frequency. Histology revealed intense OHC hair bundle abnormalities in the basal cochlea uncharacteristically associated with OHC survival and preserved coupling with the tectorial membrane. This pattern dismisses the superficial diagnosis of “hidden” neuropathy while underpinning a disorganization of cochlear frequency mapping with optimistic high-frequency auditory thresholds perhaps because responses to high frequencies are apically shifted. The audiometric advantage of frequency transposition is offset by enhanced masking by low-frequency sounds, a finding essential for guiding rehabilitation. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
48. β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.
- Author
-
Varga, Zoltan V., Matyas, Csaba, Erdelyi, Katalin, Cinar, Resat, Nieri, Daniela, Chicca, Andrea, Nemeth, Balazs Tamas, Paloczi, Janos, Lajtos, Tamas, Corey, Lukas, Hasko, Gyorgy, Gao, Bin, Kunos, George, Gertsch, Jürg, and Pacher, Pal
- Subjects
CARYOPHYLLENE ,ALCOHOLIC liver diseases ,FOOD additives ,LABORATORY rats ,POLYMERASE chain reaction ,THERAPEUTICS ,PROTEIN metabolism ,BRAIN metabolism ,ANIMAL experimentation ,ANTIGENS ,CELL receptors ,ETHANOL ,FATTY liver ,HYDROCARBONS ,IMMUNITY ,INFLAMMATION ,LIVER ,MACROPHAGES ,METABOLISM ,MICE ,ARTHRITIS Impact Measurement Scales - Abstract
Background and Aims: β-Caryophyllene (BCP) is a plant-derived FDA approved food additive with anti-inflammatory properties. Some of its beneficial effects in vivo are reported to involve activation of cannabinoid CB2 receptors that are predominantly expressed in immune cells. Here, we evaluated the translational potential of BCP using a well-established model of chronic and binge alcohol-induced liver injury.Methods: In this study, we investigated the effects of BCP on liver injury induced by chronic plus binge alcohol feeding in mice in vivo by using biochemical assays, real-time PCR and histology analyses. Serum and hepatic BCP levels were also determined by GC/MS.Results: Chronic treatment with BCP alleviated the chronic and binge alcohol-induced liver injury and inflammation by attenuating the pro-inflammatory phenotypic `M1` switch of Kupffer cells and by decreasing the expression of vascular adhesion molecules intercellular adhesion molecule 1, E-Selectin and P-Selectin, as well as the neutrophil infiltration. It also beneficially influenced hepatic metabolic dysregulation (steatosis, protein hyperacetylation and PPAR-α signalling). These protective effects of BCP against alcohol-induced liver injury were attenuated in CB2 receptor knockout mice, indicating that the beneficial effects of this natural product in liver injury involve activation of these receptors. Following acute or chronic administration, BCP was detectable both in the serum and liver tissue homogenates but not in the brain.Conclusions: Given the safety of BCP in humans, this food additive has a high translational potential in treating or preventing hepatic injury associated with oxidative stress, inflammation and steatosis.Linked Articles: This article is part of a themed section on Inventing New Therapies Without Reinventing the Wheel: The Power of Drug Repurposing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.2/issuetoc. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
49. Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions.
- Author
-
Masum, Md Abdul, Ichii, Osamu, Elewa, Yaser Hosny Ali, Teppei Nakamura, Yasuhiro Kon, Nakamura, Teppei, and Kon, Yasuhiro
- Subjects
CAPILLARIES ,KIDNEY diseases ,ANIMAL disease models ,TISSUE wounds ,AUTOIMMUNE diseases ,ANIMAL experimentation ,ANTIGENS ,BIOLOGICAL models ,GLOMERULONEPHRITIS ,KIDNEY glomerulus ,KIDNEY tubules ,MICE ,SEVERITY of illness index - Abstract
Background: The renal vasculature plays important roles in both homeostasis and pathology. In this study, we examined pathological changes in the renal microvascular in mouse models of kidney diseases.Methods: Glomerular lesions (GLs) in autoimmune disease-prone male BXSB/MpJ-Yaa (Yaa) mice and tubulointerstitial lesions (TILs) in male C57BL/6 mice subjected to unilateral ureteral obstruction (UUO) for 7 days were studied. Collected kidneys were examined using histopathological techniques. A nonparametric Mann-Whitney U test (P < 0.05) was performed to compare healthy controls and the experimental mice. The Kruskal-Wallis test was used to compare three or more groups, and multiple comparisons were performed using Scheffe's method when significant differences were observed (P < 0.05).Results: Yaa mice developed severe autoimmune glomerulonephritis, and the number of CD34+ glomerular capillaries decreased significantly in GLs compared to that in control mice. However, UUO-treated mice showed severe TILs only, and CD34+ tubulointerstitial capillaries were decreased significantly in TILs with the progression of tubulointerstitial fibrosis compared to those in untreated control kidneys. Infiltrations of B-cells, T-cells, and macrophages increased significantly in the respective lesions of both disease models (P < 0.05). In observations of vascular corrosion casts by scanning electron microscopy and of microfil rubber-perfused thick kidney sections by fluorescence microscopy, segmental absences of capillaries were observed in the GLs and TILs of Yaa and UUO-treated mice, respectively. Further, transmission electron microscopy revealed capillary endothelial injury in the respective lesions of both models. The numbers of CD34+ glomerular and tubulointerstitial capillaries were negatively correlated with all examined parameters in GLs (P < 0.05) and TILs (P < 0.01), respectively.Conclusions: From the analysis of mouse models, we identified inverse pathological correlations between the number of local capillaries in GLs and TILs and the severity of kidney diseases. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
50. Guinea worm infection in northern Nigeria: reflections on a disease approaching eradication.
- Author
-
Greenwood, Brian, Greenwood, Alice, and Bradley, Andrew
- Subjects
GUINEA worm ,INFECTION ,IMMUNOLOGY ,DOWNREGULATION ,ANTIGENS ,ALLERGIES ,ANIMAL experimentation ,BIOCHEMISTRY ,ECONOMIC aspects of diseases ,DOGS ,DRACUNCULIASIS ,PHENOMENOLOGY ,NEMATODES ,PEOPLE with disabilities ,PUBLIC health ,RESEARCH funding ,T cells ,DISEASE relapse ,INFECTIOUS disease transmission - Abstract
Copyright of Tropical Medicine & International Health is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.